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Rationale for the Alternative Format 
The current thesis is presented in the Alternative Format. As outlined by 
Lancaster University’s Manual of Academic Regulations and Procedures (MARP), 
this format allows the composition of a thesis incorporating four empirical papers 
suitable for publication (hereafter referred to as ‘publishable papers’, PPs), one of 
which can consist of a literature review in a publishable form. This choice was 
made in agreement with the candidate’s supervisors and the director of the PhD 
programme within the Division of Health Research, and was based on the nature 
of the research presented in the thesis (i.e., systematic reviews and empirical 
studies), with the ultimate aim of maximising the dissemination of findings. As 
required by MARP regulations, each publishable paper specifies the proportion for 
which credit is due to the candidate for carrying out the research and preparing 
the publication. 
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Thesis abstract 
Huntington’s disease (HD) is a progressive neurodegenerative disorder 
caused by the inheritance of the mutation of a protein called Huntingtin. Its typical 
symptoms include motor impairments, cognitive deterioration, and significant 
psychological difficulties. All these impairments can have a significant effect on the 
communication of affected individuals, including nonverbal components such as 
emotional processing. However, the current literature on HD appears to be 
particularly characterised by a medical approach to the topic, with little evidence 
from studies adopting a psychological perspective. 
Thus, the overarching aim of the current thesis was to investigate the 
impact of Huntington’s disease on the emotional processing and communication 
of affected individuals from a health psychology perspective and with the adoption 
of a mixed-methods approach. After an initial scoping review of the literature, a 
qualitative study was conducted in the first phase of the research project, with the 
aim of exploring the perspectives on communication of people with symptomatic 
HD. In the second phase, two quantitative investigations were carried out, 
specifically addressing how HD affects emotional processing – in particular 
emotion regulation and recognition – in symptomatic and presymptomatic 
individuals.  
The results showed that, although emotional processing and 
communication are affected by HD, the achievement of feelings of control, better 
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emotion regulation, effective medication regimes, and close interpersonal 
relationships can play a pivotal role in alleviating the burden of the disease. In 
addition, emotion regulation and emotional body language (EBL) recognition 
abilities were both impaired in symptomatic individuals, while evidence with 
presymptomatic people suggested a relative preservation of these skills. In both 
cases, no significant relationship was found between these abilities. However, the 
relationship between depressive symptoms and specific elements of emotion 
regulation such as emotional awareness should be further explored in 
presymptomatic participants, as it may play a potential precursory role in the 
development of emotion recognition impairments in fully symptomatic 
individuals. The implications of the findings for theory and practice are discussed, 














The history of Huntington’s disease (HD), one of the most debilitating and 
yet currently lesser-known neurodegenerative disorders, appears to be as 
convoluted as its clinical manifestation. In its earliest depictions, the disease used 
to be referred to as ‘hereditary chorea’, from the ancient Greek χορεία (choreia), 
literally ‘dance’. This is a reference to its characteristic involuntary motor 
symptoms, which have been historically compared to dancing. Other ancient 
sources dating back to the Middle Ages refer to it as Chorea Sancti Viti, or St. Vitus’s 
dance, although this term has been historically adopted for a broad range of 
neurological diseases and today is used to refer to Sydenham’s chorea (Wexler, 
2010). Despite evidence on clinical notes and reports that can be traced back to at 
least the seventeenth century (Finn, 1970), the recognition of Huntington’s disease 
as a specific clinical entity is only occurred when the American physician George 
Huntington (1850–1916) published the first comprehensive description of its 
signs and symptoms in 1872 (Huntington, 1872). Medical interest in the condition 
was not novel within the Huntington’s family: George’s grandfather, Dr Abel 
Huntington, moved to Eastern Long Island at the end of eighteenth century, where 
he found a significant number of families affected by the disease, which became 
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the main focus of his clinical work. The same applied for George’s father, a 
physician himself, who was born and raised in Long Island and took on his parent’s 
legacy (Stevenson, 1934). George’s first encounter with people affected by 
Huntington’s disease was at the age of eight, when he accompanied his father on 
one of his clinical rounds; reportedly, the impact of such a condition on his young 
mind was so strong that he decided to make it the main focus of his clinical 
education and, eventually, his first contribution to the medical literature 
(Huntington, 1910). Being raised in close and constant contact with affected 
individuals –as his father and grandfather before him – George had the unique 
opportunity to observe the development and evolution of the disease across 
several individuals and generations. Ultimately he provided a description which 
was recognised to be among the most accurate, brief and graphic in the whole 
history of medicine until that point (Osler, 1908). An example of his clearness can 
be found in the following line, where he delineated the three main features of the 
disease according to his experience: “There are three marked peculiarities in this 
disease: 1. Its hereditary nature. 2. A tendency to insanity and suicide. 3. Its 
manifesting itself as a grave disease only in adult life” (Huntington, 1872, p. 320). 
Even though he seemed to ignore the existence of a juvenile onset (i.e., before age 
20), which is rare but possible (Kremer, 2002), the hereditary nature of the disease 
and its main psychological and cognitive difficulties appeared to be very clear in 
his mind. In particular, it is worth noting the sharpness of the description of the 
genetic transmission of the disease, implicitly outlining an autosomal-dominant 
mechanism almost 30 years before Hugo de Vries, Carl Correns and Erich von 
Tschermak made Mendel’s laws known worldwide in 1900.   
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Humbly, George Huntington never omitted mentioning the contribution 
of his father and grandfather in his success: “as in old Greece the pupil sat at the 
feet of his teacher, so your essayist sat at the feet of these two, and whatever of 
honour, whatever of praise, whatever of scientific worth there is, is due much more 
to them, than to him to whom has come this unsought, unlooked for honour” 
(Stevenson, 1934, p. 62). Therefore the eponym ‘Huntington’s chorea’, which 
became very popular among authors after the seminal publication of 1872 (see 
Figure 1 for an illustration of the original front page) and was later acquired even 
in more informal registers, can be considered as one created by a whole family 
rather than a single man. Since approximately the 1970s, however, the term 
‘disease’ has started to be preferred to highlight the fact that the motor 
impairments are not the only feature of the condition, as well as to avoid any 
possible stigma attached to it (Novak & Tabrizi, 2005; Wexler, 2010). 
Aetiology 
Despite its clear hereditary aetiology and notwithstanding intense 
research activity across the whole twentieth century, the specific genetic cause of 
Huntington’s disease was not identified until 1993, i.e. more than 120 years after 
the first scientific establishment of the condition. This occurred when the mutation 
of a protein (from then on named ‘Huntingtin’, or HTT) was recognised to be 
responsible for an anomalous expansion of CAG trinucleotide (cytosine-adenin-
guanin) repeats on the short arm of chromosome 4 (Huntington’s Disease 
Collaborative Research Group, 1993). The protein is normally present in an 
individual’s biological make-up, regardless of sex or ethnicity, and it usually 
expresses a regular number of CAG repeats up to 28; when a mutation occurs, 
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however, the number of repeats increase, eventually leading to substantial 
damage to the subcortical regions of the brain called the basal ganglia. Especially 
affected is the corpus striatum (composed by the caudate nucleus and the 
putamen), which is involved in the many behavioural, cognitive, and motor tasks 
that are impaired in Huntington’s disease.   
As inferred by George Huntington, the mutation is hereditary and the 
transmission mechanism is autosomal-dominant, meaning that every affected 
individual has a 50% probability of transmitting it to their children regardless of 
the condition of the other parent. In most cases the disease is fully penetrant, i.e. 
all the individuals with the mutant gene will develop the disease at a certain time 
in their life. More specifically, the probability of developing the disease varies 
according to the number of CAG repeats on the allele: up to 35 repeats are not 
associated with the disease, 41 or more repeats are associated with full penetrance 
(and therefore the individual will surely develop the disease), while a number of 
repeats between 36 and 40 is associated with a ‘grey zone’ of incomplete 
penetrance, in which the individual may or may not develop the disease during 
his/her lifetime (Walker, 2007). This ‘grey zone’ is thought to account for 5 to 10% 
of new cases which are not explained by family history, often due to instable 
replication on the fathers’ side that increases the number of repeats from 28 to 36 
or more, thus reaching incomplete or complete penetrance (Semaka, Collins, & 
Hayden, 2010).  
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Figure 1: Front page of the George Huntington’s 1872 research article featuring the first 
depiction of HD.  
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Epidemiology  
Huntington’s disease is a rare condition, showing a prevalence of 5-10 
persons per 100,000 in the Caucasian population (Roos, 2010). As far as the UK is 
specifically concerned, the reported prevalence in 2010 was 12.3 per 100,000 
people (Evans et al., 2013). A recent systematic review and meta-analysis of its 
worldwide incidence and prevalence found an overall prevalence of 2.71 per 
100,000 (Pringsheim et al., 2012). More specifically, the overall prevalence was 
5.70 per 100,000 in Europe, North American, and Australia, while in Asia it showed 
a much lower presence, with an overall prevalence of 0.40 per 100,000. Incidence 
was reported to be 0.38 per 100,000 per year worldwide, again with lower values 
for Asian countries. This significant geographical difference between Asia and the 
remaining continents is thought to be due to differences in individuals’ haplotypes, 
i.e. Asian people generally have shorter CAG tracts that may prevent them from 
developing the abnormal number of repeats typical of the disease.  
Genetic testing and diagnosis 
Since the discovery of the protein responsible for the disease in 1993, 
genetic testing is available for individuals with a family history, allowing them to 
know if they carry the mutant gene even decades before the onset of symptoms. 
Nonetheless, the number of at-risk people who decide to undertake the test  ranges 
between 3% and 24% (Harper, Lim, & Craufurd, 2000; Laccone et al., 1999), with 
the lowest uptake observed in Germany, Austria and Switzerland (3-4%) and the 
highest observed in the UK (18%), Canada (18%) and the Netherlands (24%; 
Tibben, 2007). With particular regard to the UK, a recent investigation of data 
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between 1993 and 2012 showed an overall uptake of predictive testing ranging 
between 15% and 26% (Quarrell & Rosser, 2014).  
A positive genetic test, however, has no clinical value per se and does not 
constitute a diagnosis. The full diagnosis of Huntington’s disease is based on 
clinical symptoms and signs along with a familiar history (i.e., proof of an affected 
parent); more specifically, the current necessary clinical criteria for diagnosis are 
still motor symptoms, while the presence of cognitive and psychological changes 
is not necessary (Roos, 2010). People with a positive test for Huntington’s but 
without motor symptoms are usually referred to as being ‘gene carriers’ or having 
‘presymptomatic HD’ or ‘premanifest HD’ (Dumas, van den Bogaard, Middelkoop, 
& Roos, 2013), while individuals with family history of the disease who have not 
been tested are usually defined as ‘at-risk’ (Chisholm, Flavin, Paulsen, & Ready, 
2013). 
Onset and life expectancy 
The estimate range of age of onset is 40-50 years. However, juvenile onset 
(i.e. before the age of 20 years and as early as 2 years) can also occur, as well as a 
very late onset (up to 80 years; Kremer, 2002). Juvenile Huntington’s disease (JHD) 
is usually characterised by more prominent slowing of movements, lack of 
muscular tone as well as psychological difficulties such as agitations and 
irritability  (Roos, 2010). The specific age of onset appears to be determined by 
both genetic and environmental factors, with the number of CAG repeats 
accounting for approximately the 60% its variation (Walker, 2007). No effective 
treatment or cure has been found so far and the mean life expectancy after the 
diagnosis is typically 20 years (Folstein, 1989).   
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Motor symptoms and signs 
The characteristic motor symptom of Huntington’s disease is represented 
by involuntary movements (chorea) that initially start from the distal extremities 
of the body (fingers and toes) and gradually involve more proximal muscles, 
including the head and the face. The choreatic movements are not characterised 
by any specific pattern. They are always present when the affected individual is 
awake, though tend to disappear during sleep. As the disease progresses, 
hypokinesia (decreased body movements), akinesia (difficulty in starting 
movements), bradykinesia (slower movements), dystonia (muscle contractions 
causing twisting movements and uncomfortable postures) and dysphagia 
(difficulty in swallowing) appear. As a consequence, walking becomes unstable 
and normal daily activities such as eating, drinking and talking become 
progressively arduous (Roos, 2010).  
Cognitive symptoms  
Huntington’s disease is responsible for many cognitive impairments, 
ultimately leading to dementia. A recent review including studies between 1993 
and 2011  found that in manifest Huntington’s disease impairments can be 
expected in memory, psychomotor speed, executive functioning and, in later 
stages, language (Dumas et al., 2013). In presymptomatic individuals no difference 
is usually found in terms of linguistic and long-term memory function when 
compared to control groups, while an early deterioration of executive processes 
and working memory is sometimes observed (Dumas et al., 2012; You et al., 2014).
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Psychological difficulties and well-being 
Huntington’s disease is also associated with a number of psychological 
difficulties, of which the most frequent are depression, euphoric or dysphoric 
mood, lack of inhibition, irritability and aggressiveness, as well as anxiety, 
agitation, and apathy; more rarely delusions, compulsions, and hallucinations can 
be observed (Beglinger & Paulsen, 2008; Caletti et al., 2014; Robins Wahlin, 2007; 
Santacruz, Fenoll, & Munoz, 2014; Vaccarino et al., 2011; van Duijn, Kingma, & van 
der Mast, 2007; Walker, 2007). Moreover, an increased risk of suicide has often 
been found in presymptomatic people (Hubers et al., 2012). In particular, along 
with cognitive impairments, depression has been reported to be a highly 
significant determinant of the quality of life of affected individuals (Banaszkiewicz 
et al., 2012), even more than motor symptoms themselves.  Another psychological 
challenging aspect of HD is represented by the impact of predictive testing. With 
regard to this, as shown by the aforementioned generally low uptake, most at-risk 
individuals prefer to remain uncertain about their gene status and undergo the 
test only when they are facing important life choices, such as getting married or 
having children. On the other side, the studies on those who have undergone the 
test and received a positive result show a consistent variability: some people show 
average levels of psychological distress in the long term (e.g., after 1 year) and start 
to appreciate life and relationships more (Broadstock, Michie, & Marteau, 2000; 
Duisterhof & Trijsburg, 2001), while others regret being tested and tend to avoid 
any further investment in education, jobs, family, or long term life plans in general 
(Hagberg, Bui, & Winnberg, 2011). In some cases a positive test result has been 
associated with suicidal ideation (Wahlin, 2007). Other psychological difficulties 
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reported by people with Huntington’s disease include genetic discrimination (i.e., 
being treated unfairly or differently by others due to genetic differences, as 
opposed to physical ones; Bombard et al., 2011; Williams & Erwin, 2010), family 
issues due to living with affected relatives and communicating the family history 
with the disease, especially when young children are involved (Forrest Keenan, 
van Teijlingen, McKee, Miedzybrodzka, & Simpson, 2009). With regard to this, a 
framework that has been often adopted to explain psychological difficulties in 
chronic illnesses is the self-regulation model (SRM; Leventhal, Leventhal, & 
Brissette, 2003), which identifies patients’ perceptions of their chronic condition 
as a fundamental element that plays a pivotal role in informing the development 
of coping strategies – which in turn deeply affect the successful operationalisation 
of psychological well-being (for a review, see Hagger et al., 2017). In the specific 
case of HD, a more psychological distress is associated with a strong illness identity 
(i.e., a belief that a high number of symptoms are perceived as attributable to the 
disease), as well as by a perception of HD as a chronic condition responsible for 
many negative consequences (Arran, Craufurd, & Simpson, 2014; Helder et al., 
2002; Helder & Kaptein, 2002; Kaptein et al., 2006;  Kaptein et al., 2007; Klitzman, 
2009).  
However, despite the research mentioned above, psychological accounts 
of patients’ lived experience are not as evident as those from a more medical, 
neurological perspective and very little is currently know about how affected 
people live their lives, manage their emotions, relate and communicate to others, 
and ultimately make sense of the condition (Audulv, Packer, & Versnel, 2014).  
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Chapter 2 
 
Overview and Justification of Methods 
Multimethod and Mixed Methods Research (MMMR) 
General overview 
The combination of different types of research methods within the same 
set of studies has traditionally met with lukewarm approval. Indeed, although the 
adoption of multiple methods can be traced back to the beginning of the 20th 
century – especially in the case of social science research –a clear case for its 
empirical usefulness only occurred in far more recent times (Mark, 2015). One of 
the possible reasons for this may lie in the variety of definitions that has 
characterised this approach over the past few decades, and that has led to the 
development of terms such as ‘mixed methods’ or ‘multimethod’ which, although 
conceptually very close, can have substantial semantic differences. According to 
the Oxford Handbook of Mixed and Multimethod Research Inquiry (Hesse-Biber & 
Johnson, 2015), the word ‘multimethod’ refers to the general combination of two 
or more different methods, whether qualitative or quantitative, in the context of a 
single study or a series of scientific works. Therefore, it can broadly delineate 
either the adoption of quantitative and qualitative methods together, or the 
combination of a series of different quantitative (or qualitative) methods. This can 
also be expressed with the variation ‘multiple methods’. On the other hand, ‘mixed 
methods’ is a narrower term that refers to the specific combination of both 
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quantitative and qualitative in the same research context. In order to express this 
distinction, the collective term ‘multimethod and mixed methods research’ 
(MMMR) can be adopted (Hesse-Biber & Johnson, 2015). 
Philosophical underpinnings of MMMR: the third paradigm 
Historically, the dispute between quantitative and qualitative 
methodologies has been a philosophical one, as their fundamental differences 
stem from what is considered to be real (ontology), and how reality can be known 
(epistemology). This has driven the development of two main opposing scientific 
paradigms. On one side positivism (and later post-positivism), characterised by 
the belief that reality is unique, objective and knowable through bias-free 
measures (realism). On the other, constructivism (also known as interpretivism), 
which entails the belief that there is no unique reality, but rather a number of 
subjective constructs depending on contexts that can only be interpreted 
(relativism). As a reflection of these assumptions, positivism has traditionally 
adopted quantitative methodologies, and constructivism has been characterised 
by qualitative approaches (Bishop, 2015). While the first half of the 20th century 
was largely dominated by positivistic science, in the 1970s constructivism and 
other forms of relativistic paradigms started to challenge the realist approach 
(Alise & Teddlie, 2010). This quickly escalated into what came to be known as the 
‘paradigm wars’ (Mertens, 2014; Oakley, 1999; Tashakkori & Teddlie, 1998), 
which were driven by the assumption that the paradigms were epistemologically 
incoherent with one another and therefore could not be combined (the 
‘incompatibility thesis’; Howe, 1988).  The paradigmatic divide was so prominent 
that graduate students in those years (and likely still today, in some cases) 
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reportedly felt as if they were asked to pledge allegiance to one ‘faction’ or the 
other in order to work in academia (Johnson & Onwuegbuzie, 2004). 
It was not until two decades ago that, in reaction to the paradigm wars, a 
number of theorists counter-proposed the ‘compatibility thesis’, leading the way 
to the first affirmation of MMMR (Alise & Teddlie, 2010) under the idea that 
functional knowledge should be prioritised over philosophical disputes – a 
position known as ‘pragmatism’.  The core assumption of pragmatism is that 
methodological choices do not need to commit to any single ontology and 
epistemology, but can, rather, be driven by the practical implications of the 
questions that are being examined and the results that are being sought (Dures, 
Rumsey, Morris, & Gleeson, 2010; Johnson & Onwuegbuzie, 2004). This enables 
researchers to draw from a ‘toolkit’ of both quantitative and qualitative methods 
and base their rationale on the needs and purposes of the research rather than 
their philosophical stance (Maxwell & Mittapalli, 2010). As a consequence, due to 
this shift of focus on purposes, pragmatism has often been regarded as the ‘third 
paradigm’ in the philosophical scene (Onwuegbuzie & Leech, 2005), as well as the 
‘philosophical partner’ for MMMR (Johnson & Onwuegbuzie, 2004), especially in 
real world research contexts such as health and social sciences.  
MMMR in health research and psychology 
Since its initial inception as a scientific discipline, psychology has been 
largely dominated by quantitative methodological approaches (Alise & Teddlie, 
2010). Indeed, its early characterisation as a scientific discipline was clearly 
reflected in its adoption of a positivist approach.  Since then, the strength of the 
positivist influence has been so significant that, even with the advent of 
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constructivism, mainstream psychology has always maintained a quantitative 
stance, with very little (if any) interest in the integration of qualitative components 
with quantitative research (Frost & Shaw, 2015). This dominion remained 
unchallenged until at least the 1980s, when the abovementioned paradigm wars 
triggered a renewed interest for qualitative methods, especially in the field of 
social psychology (Oakley, 1999). Nevertheless, any early attempts at adopting 
MMMR in psychology were frustrated by the prevailing incompatibility thesis, 
which led to a fierce entrenchment on paradigmatic and methodological positions 
(whether post-positivist/quantitative or constructivist/qualitative). This was 
argued to put at risk the very purpose of scientific inquiry, that is, the advancement 
of knowledge – a phenomenon that was later defined as ‘methodolatry’ (Curt, 
1994). 
However, the history of psychology has also been characterised by a rich 
tradition of methodological experimentation. As a consequence, the psychological 
panorama has seen a substantial proliferation of methods and techniques, which 
appears to have reached its peak in the last few decades thanks to the advent of 
cognitive neuroscience. In addition, as mentioned before, the interest in 
qualitative methods that characterised the paradigm wars period has continued to 
favour the compatibility thesis and, now that ‘a fragile peace’ (Bryman, 2006) has 
been achieved, the time seems ripe for a renewed attempt at exploring the 
possibilities of MMMR in psychology and related disciplines.  
In fact, this appears to be particularly the case in health research (Morgan, 
1998). Driven by a more pragmatic logic of inquiry that is focused on the impact of 
research on practice rather than maintaining a precise methodological stance 
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(Maxcy, 2003), applied health research has largely embraced the adoption of 
MMMR (Frost & Shaw, 2015). This occurred to the extent of seeing it become one 
of the dominating methodological approaches in the field (Ó’Catháin, Murphy, & 
Nicholl, 2010), within the context of what has been defined as a ‘quiet revolution’ 
(Halcomb & Andrew, 2009; Tashakkori & Teddlie, 2003). With particular regard 
to the UK, the recommendation of including qualitative designs along with 
quantitative studies in health research was initially proposed by the Medical 
Research Council (MRC, 2000), and has been more recently endorsed by the 
National Institute for Health and Care Excellence (NICE) in England and Wales 
(Kelly et al., 2009), as well as the Scottish Intercollegiate Guidelines Network 
(SIGN; 2008). As a subfield of health research, a similar tendency has been 
consequently observed in the field of health psychology, in which the adoption of 
MMMR can promote the widening of perspectives in research on clinical practice 
and outcomes (Mcleod, 2011), as well as the exploration of  subjective dimensions 
and experiences that may otherwise go overlooked (Bryman, 2007). In 
confirmation of this, in 2005 the Journal of Counseling Psychology published a 
special issue entitled A Time and Place for Qualitative and Mixed Methods in 
Counseling Psychology Research meant as “a call to counseling researchers to 
increase their dialogue over philosophy of science, research paradigms, and 
methodological diversity” (Haverkamp, Ponterotto, & Morrow, 2005, p. 123). 
Similarly, in 2015 Health Psychology published a special issue on qualitative 
research with the aim of “promoting greater uptake and development of 
qualitative research methods in the field” (Gough & Deatrick, 2015, p. 1). 
Concurrently, in recent years  the psychological literature in the UK has seen a 
substantial increase of the acknowledgement of the usefulness and value of MMMR 
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(e.g., Bishop, 2015; Bryman, 2007; Cornish & Gillespie, 2009; Dures et al., 2010; 
Mason, 2006; Todd, Nerlich, & McKeown, 2004), driven by the recognition that 
“the range of ways in which methods can be mixed, be they with others of the same 
paradigm or across paradigms, allows the complexity of humanness to be better 
represented” (Frost & Shaw, 2015, p. 389).  
General purposes and rationales for MMMR 
Due to its focus research on functional knowledge and practical 
implications, since the 1980s several models have been proposed to characterise 
the breadth of aims and purposes that can justify the adoption of MMMR. Despite 
some variability in terms, a number of common concepts can be recognised in all 
of them. These include the purpose of triangulating information onto a single 
answer (e.g., Rossman & Wilson, 1985), widening the range of answers (e.g.,  Mark 
& Shotland, 1987), providing different levels of analysis, or enhancing 
interpretability of the results. From this perspective, the most influential model is 
the classification proposed by Greene and colleagues (1989), in which they 
identified five possible purposes for MMMR: a) triangulation, that is, searching for 
convergence and corroboration across methods; b) complementarity, that is, 
enriching the elaboration and clarification of findings; c) development, that is, 
adopting a method to develop or inform the adoption of another one; d) initiation, 
that is, searching for contradictions and generating new research perspectives; e) 
expansion, that is, utilising different methods for different components of a 
research design. Apart from research purposes, the same author also developed a 
list of other four of dimensions along which MMMR designs can differ (Greene, 
2007). These include the sequence of studies (timing), the hierarchical importance 
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of methods (status), whether one study informs any others (dependence), and the 
adopted measures and methods (methods themselves). The particular advantage of 
Greene’s model lies in the potential for the researcher to draw a methodological 
framework based on its dimensions. Thus, this model was adopted for the 
development of the methodological framework of this thesis.  
Philosophical and Methodological Foundations of the Thesis 
Rationale for MMMR adoption 
As previously noted, MMMR is a methodological approach that is 
considered to fit exceptionally well with the needs and purposes of the field of 
health research and health psychology (Bryman, 2007; Cornish & Gillespie, 2009; 
Frost & Shaw, 2015; Halcomb & Andrew, 2009; Mason, 2006; Maxcy, 2003; 
Morgan, 1998; Ó’Catháin et al., 2010; Todd et al., 2004), especially in the UK (Kelly 
et al., 2009; Medical Research Council, 2000; Scottish Intercollegiate Guideline 
Network, 2008). In particular, MMMR has been reported to benefit  considerably 
the investigation of the complex phenomena related to the interface between 
health psychology and rare or chronic illness (Bishop, 2015; Dures et al., 2010), in 
a fashion that cannot be achieved by the adoption of quantitative methods alone 
(Crossley, 2000). This consideration, combined with the philosophical position of 
the researcher (see next paragraph), has led to the decision to adopt MMMR for 
the research topic of the current thesis, that is, the exploration of the psychological 
impact of a rare and chronic condition such as Huntington’s disease on patients’ 
emotional processing and communication.  
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Philosophical stance 
As mentioned before, the ideal philosophical stance for the adoption of 
MMMR is often regarded to be a pragmatic one (Johnson & Onwuegbuzie, 2004). 
Indeed, since its first introduction, pragmatism has been very popular among 
MMMR researchers (Biesta, 2010; Cornish & Gillespie, 2009; Johnson & Gray, 
2010; Maxcy, 2003; Morgan, 2014). Nevertheless, when considered from an 
ontological and epistemological point of view, the pragmatic approach has 
considerable limitations and shortcomings. In particular, the extent to which it 
rejects the role of philosophical assumptions has been the subject of growing 
criticism over the years (Johnson & Onwuegbuzie, 2004), as it may lead to a 
misleading underestimation of the influence of researchers’ ontological and 
epistemological positions on the chosen methodology, as well as on research 
questions, purposes and, ultimately, findings (Henry, Julnes, & Mark, 1998; 
Maxwell & Mittapalli, 2010).  
One of the aims of this work was to carry out research that accounts for 
the heterogeneous and dynamic nature of complex psychological phenomena 
linked to Huntington’s disease as well as being explicit regarding the potential 
influence of the philosophical assumptions of the researcher. As a consequence, 
instead of a pragmatic approach, a critical realist stance was adopted for the 
current thesis. In the philosophy of science, critical realism emerged out of the 
work of Roy Bhaskar (1978). Its distinctive characteristic is that, while it retains a 
realist ontology (i.e., there is a unique reality that we can investigate), it embraces 
a relativist epistemology – that is, our knowledge of reality cannot be objective or 
certain, as it will always depend on our perspectives, values, and contexts. Thus, 
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on one hand critical realism is akin to pragmatism as it agrees with the justification 
of methods based on the aims and purposes of research. However, on the other 
hand, it differs from it by retaining a focus on philosophical assumptions, without 
having the unrealistic expectation for researchers to dismiss what, in fact, is the 
subjective lens through which they observe the world and make sense of their 
findings (Greene & Hall, 2010). From this viewpoint, critical realism not only 
recognises the importance of physical and behavioural entities, but also considers 
people’s meanings and perspectives as equally real and separate phenomena with 
explanatory significance that can deepen and expand the interpretation of findings 
(Sayer, 2000). In terms of methodology, this offers compatibility with both 
quantitative and qualitative methods. Indeed, more than just representing an 
effective tool for bridging the two (Mark, Henry, & Julnes, 2000), critical realism 
also has “important implications for both approaches, ones that push both 
qualitative and quantitative researchers to examine more closely some issues that 
they typically dismiss or ignore” (Maxwell & Mittapalli, 2010, p.160). 
Therefore, critical realism was considered to be consistent with the 
research planned for this thesis, as well as the researcher’s philosophical 
assumptions and values. More specifically, a critical realist stance appeared to be 
particularly indicated for the exploration and integration of qualitative data on the 
perspectives of people with Huntington’s disease (PP2) with cognitive 
quantitative findings on their psychological difficulties (PP3 and PP4).    
Methodological framework 
In accordance with Greene’s model (Greene, 2007; Greene et al., 1989), a 
methodological framework was drawn for the current thesis. In particular, MMMR 
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was adopted for two main purposes: allowing the initial exploratory studies to 
inform the methods of the later ones (development), and enriching the elaboration 
and understanding of the psychological influence of HD by diversifying the type of 
data (complementarity). The methods included both quantitative and qualitative 
studies. For this reason, in accordance with the aforementioned distinction 
between multimethod and mixed methods research (Hesse-Biber & Johnson, 
2015), the term mixed methods was chosen to refer to the approach adopted in 
the present work. As a direct consequence of the development purpose, the timing 
of the methods was sequential and their relationship was characterised by linear 
dependence. Last, despite more quantitative studies, the status of the methods was 
overall equal in standing. Table 1 provides a schematic representation of the 
methodological framework of the thesis.  
Table 1 
 
Methodological framework of the thesis (based on Greene’s model, 2007; 1989) 
Dimension Thesis 




Methods Quantitative and qualitative 
Overview of the mixed methods design  
As far as the technicalities and practicalities of mixing methods are 
concerned, the solution adopted by most authors has been to develop typologies 
of mixed methods designs. Consequently, the last few decades have seen a 
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considerable proliferation of models illustrating several typologies and examples 
(Bishop, 2015). Among these, one of the most recent and influential is the model 
developed by Johnson and Onwuegbuzie (2004). Inspired by a number of previous 
works (Creswell, 1994; Morgan, 1998; Morse, 1991; Patton & Quinn, 1990; 
Tashakkori & Teddlie, 2003), it is based on two primary decisions: the emphasis 
assigned to different paradigms (intended as qualitative or quantitative 
components, therefore equivalent to Greene’s status) and the time order of the 
studies (equivalent to Greene’s timing). As a result, the model provides a decision 
matrix in which nine typologies of mixed methods designs are identified: 
concurrent equal mixed methods (QUALITATIVE + QUANTITATIVE), concurrent 
unequal mixed methods (QUALITATIVE + quantitative; quantitative + 
QUALITATIVE), sequential equal mixed methods (QUALITATIVE  
QUANTITATIVE; QUANTITATIVE  QUALITATIVE), and sequential unequal 
mixed methods (QUALITATIVE  quantitative; qualitative  QUANTITATIVE; 
QUANTITATIVE  qualitative; quantitative  QUALITATIVE). Table 2 provides 
an adapted schematic overview of Johnson and Onwuegbuzie’s matrix (2004). Due 
to its compatibility with Greene’s methodological framework (Greene, 2007; 
Greene et al., 1989) and its focus on paradigm emphasis and timing, Johnson and 
Onwuegbuzie’s typology was adopted for the current thesis. In particular, a 
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Table 2  
 
Mixed methods design matrix (adapted from Johnson and Onwuegbuzie, 2004) 



















Equal QUAL + QUAN 
QUAL  QUAN 
QUAN  QUAL 
Unequal 
QUAL + quan 
QUAN + qual 
QUAL  quan 
qual  QUAN 
 
QUAN  qual 
quan  QUAL 
Note. qual = qualitative; quan = quantitative; + = concurrent;  = sequential; upper case = high 
emphasis; lower case = low emphasis; bold = design typology adopted in the current thesis.  
This decision was made for a number of reasons. First of all, as outlined in 
the thesis methodological framework (Table 1), one of the purposes for the 
adoption of MMMR was to enrich and diversify the type of data. As a consequence, 
an equal emphasis was given to both qualitative and quantitative methods. 
Secondly, the choice of developing a sequential design was motivated by the 
second purpose of the framework, i.e. allowing the initial studies to inform the 
following ones. This was also compatible with the recommendations of the ESRC 
postgraduate training and development guidelines for PhD students (ESRC, 2009), 
as well as the guidance for trainee health psychologists (Health Professions 
Council, 2010), since it allows the development of both quantitative and 
qualitative research skills. Last, a sequential design better lends itself to a number 
of separate publications (Bishop, 2015), which benefit the purposes of an 
alternative format thesis.  
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Synopsis of studies and methods 
As mentioned before, the overarching aim for the current thesis was to 
investigate the impact of Huntington’s disease on the communication of affected 
individuals. This research question, along with the critical realist position of the 
researcher, informed the adoption of a mixed methods design, as well as the choice 
of methods and the sequence of studies1.  
First, a scoping review of the literature on communication in people 
affected by Huntington’s disease (PP1) was conducted, with the aim of identifying 
the elements of communication that had been investigated, as well as capturing 
and describing the variety of research perspectives adopted. The scoping 
approach was chosen as it allowed the use of a systematic and replicable search 
strategy without specifying a narrowly defined research question, as usually 
required by systematic reviews (Arksey & O’Malley, 2005; Mays, Roberts, & Popay, 
2001) and for which the paucity of research in more specific and narrower areas 
on communication in HD was problematic. Both quantitative and qualitative 
studies were included. The results outlined a number of elements of 
communication that had been particularly neglected in the empirical literature. 
These included the subjective experiences and perspectives on communication of 
people affected by HD, as well as some components of emotional processing, such 
as emotion recognition through non-facial cues (e.g., body language). 
                                                        
1 For the purpose of this chapter, only a brief overview of methods is provided. The full rationale 
and justification for each method can be found in the respective publishable papers (PPs). 
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Informed by the literature review, a study aimed at exploring the 
perspectives on communication of people with HD (PP2) was then developed. A 
qualitative design was adopted, based on semi-structured interviews and analysed 
through thematic analysis (TA). The choice of TA was driven by its recognised 
usefulness within the field of psychology and communication disorders (Braun & 
Clarke, 2006), as well as for its flexibility towards both deductive (i.e., theory-
driven) and inductive (i.e., data-driven) analyses of the themes (Harper & 
Thompson, 2011). Apart from the paucity of qualitative literature on the topic that 
was identified by the review, the decision of starting with a qualitative 
investigation was motivated by the idea that exploring patients’ perspectives 
would facilitate insights into aspects of communication that may potentially be 
overlooked in quantitative studies. This was also believed to allow the lines of 
enquiry to be kept open for a later, more focused quantitative exploration. Indeed, 
the results provided useful insights around the subjective experience of the 
communicative issues experienced by people with HD. Among these, one of the 
most relevant was how HD impaired communication by threatening participants’ 
emotional life and stability, and how one possible solution was represented by 
improving emotion regulation.  
Thus, based on the results of the qualitative study, and co-informed by the 
observation that no quantitative literature on the topic had been retrieved by the 
initial scoping review, a quantitative investigation of the impact of HD on emotion 
regulation was planned. More specifically, two similarly designed yet distinct 
studies with age-matched controls were developed: an online survey with people 
with presymptomatic HD (PP3) and a face-to-face between-subject study with 
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individuals affected by symptomatic HD (PP4). This differentiation was motivated 
by the characteristics of the research samples. An online survey was considered 
more appropriate for presymptomatic people, as it allowed for the enrolment of 
high numbers of participants in different countries thanks to dissemination via 
email and social media. This was not the case for symptomatic participants, due to 
the difficulties in using computers and digital devices in general that are often 
caused by the motor symptoms of the disease. On the other hand, a face-to-face 
between subject design was considered more suitable for symptomatic 
individuals, as the presence of the researcher allowed for the arrangement of any 
required facilitations (e.g., presenting the stimuli on a computer). As a 
consequence, due to HD’s low prevalence, this translated into a much smaller 
sample compared to the online survey. However, the number of symptomatic 
participants enrolled (13) was consistent with the average sample size of similar 
research identified by the initial scoping review. The overarching aim of both 
studies was to investigate how HD affects emotion regulation, and how that relates 
to emotion recognition. The latter component was included due to the alterations 
and impairments of emotion recognition that are known to be present in both 
presymptomatic and symptomatic individuals (Novak & Tabrizi, 2005). In 
addition, as one of the most neglected topics identified by the scoping review was 
emotion recognition via non-facial cues, a test of emotion recognition based on 
body language stimuli was included in PP4.  
The results of PP3 showed that, in presymptomatic people, emotion 
regulation and emotion recognition are not significantly impaired, and no 
significant relationship between the two constructs was observed. However, a 
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specific impairment of the emotional awareness component was found, which 
appeared to be enhanced by the co-occurrence of depressive symptoms, even at a 
subclinical level. In addition, this impairment may represent a precursor of 
emotion the recognition impairment for negative emotions that is typically 
observed in individuals affected by fully symptomatic HD. On the other hand, the 
results of PP4 showed that emotion regulation and emotional body language 
recognition are significantly impaired in people with symptomatic HD. In addition, 
emotional body language recognition impairments were significantly related to 
both facial emotion recognition deficits (positively) and the stage of the disease 
(negatively). However, as in PP3, no significant correlation was observed between 
emotion regulation and recognition performances. 
A visual representation of the overall sequence and logic of the studies is 
provided by the flowchart depicted in Figure 1. In terms of research design and 
methods, a similar approach to the current thesis has been adopted before in 
health psychology for the investigation of the psychological impact of chronic and 
rare illness. More specifically, it was adopted with people affected by 
epidermolysis bullosa (EB),  where it proved to be a suitable solution for the 
research questions and purposes (Dures, Morris, Gleeson, & Rumsey, 2010; Dures 
et al., 2010; Dures, Morris, Gleeson, & Rumsey, 2011). Last, a ‘theoretical 
integration’ (Moran-Ellis et al., 2006) of the findings of all the studies is provided 
in the General Discussion chapter. 
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Figure 2: Thesis studies flowchart.   
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• We reviewed communication in people with symptomatic Huntington’s disease 
(HD). 
• 49 studies were included. 
• 4 topic areas were identified: communicative skills, emotion, language and 
speech.  
• HD primarily impairs language, negative emotions recognition and speech 
production. 







Objectives: Communication is a multifaceted ability that includes language, 
emotion, speech, and social and environmental factors. It is particularly relevant in the 
process of adjusting to chronic illnesses such as Huntington’s disease, with 
communicative patterns being significantly related to clinical outcomes. This review 
aimed at identifying the elements of communication that have been investigated with 
people with symptomatic Huntington’s disease, the breadth of research perspectives, and 
the differing methodological approaches. 
Methods: A scoping review was conducted. Three databases - PubMed, PsycINFO 
and LLBA - were searched systematically from January 1993 to January 2015, using MeSH 
and Subject Terms as well as general keywords.  
Results: Forty-nine eligible studies were identified across four topic areas; 
Communicative Skills, Emotion, Language, and Speech. 
Discussion: Huntington’s disease severely impairs language skills, recognition of 
negative emotions, and speech when compared to controls. Preliminary evidence was also 
found for the impact of social and environmental factors on communicative abilities. 
Directions identified for future research include more comprehensive investigations of 
patients’ perspectives, emotion expression and other nonverbal components of 
communication, as well as the effect of both impairments and social factors on the 
functional communicative capacity of people with symptomatic Huntington’s disease. 
Keywords: Huntington's disease; communication; emotion recognition; 




Huntington’s disease (HD) is a neurodegenerative disorder caused by the 
mutation of a protein called Huntingtin, situated on the short arm of chromosome 4. 
Typical symptoms include motor impairments, cognitive deterioration and significant 
psychological difficulties (Novak & Tabrizi, 2005). The mutation is hereditary and the 
transmission mechanism is autosomal-dominant, meaning that every affected individual 
has a 50% probability of transmitting the mutation to their children, regardless of the 
condition of the other parent. In the vast majority of cases the disease is fully penetrant, 
i.e. all the individuals with the mutant gene will develop the disease at a certain time in 
their life.  
HD is considered a rare illness, with a prevalence of approximately 5-10 persons 
per 100,000 in the Caucasian population (Roos, 2010). A recent systematic review and 
meta-analysis of its worldwide incidence and prevalence (Pringsheim et al., 2012) found 
an overall prevalence of 2.71 per 100,000. Genetic testing is available in most medically 
developed countries for individuals with a family history of the disease, allowing them to 
know if they carry the mutant gene even decades before the potential onset. People with 
positive testing for HD without motor symptoms are usually referred to as ‘gene carriers’ 
or people with ‘pre-symptomatic HD’ (Dumas, van den Bogaard, Middelkoop, & Roos, 
2013), while individuals with family history of the disease who have not been tested are 
usually defined as ‘at-risk’ (Chisholm, Flavin, Paulsen, & Ready, 2013). The estimate range 
of age onset is 40 to 50 years. However, juvenile onset (before the age of 20 and as early 
as 2 years) can also occur. No cure has been found so far and the mean life expectancy 




The characteristic motor symptom of HD is involuntary movements (chorea) that 
involve the limbs as well as the face. As the disease progresses, walking becomes unstable 
and normal daily activities such as eating, drinking and talking become progressively 
arduous (Roos, 2010). HD is also responsible for many cognitive impairments, which 
include problems with memory, psychomotor speed, executive functioning and language, 
and ultimately lead to dementia (Dumas et al., 2013). A number of psychological 
difficulties can appear throughout the progression of the disease, of which the most 
frequent commonly reported are depression, euphoria (or dysphoria), lack of inhibition, 
increased irritability and aggressiveness, tendency to feel anxious, more agitated or 
apathetic; more rarely, delusions, compulsions, increased sexual drive and hallucinations 
can be observed (Walker, 2007).  
Individual differences in ‘adjustment’ to chronic and disabling illnesses 
(understood here as the way people adapt “to maintain a positive view of the self and the 
world in the face of a health problem”(Sharpe & Curran, 2006), p1161) and the causes 
which may affect them, such as different coping strategies, gender and socio-cultural 
factors, have long been a focus of investigation in other neurodegenerative conditions 
(Leventhal, Leventhal, & Brissette, 2003). Among the factors affecting adjustment to 
chronic illness, a pivotal role is played by interpersonal communication (Stanton, 
Revenson, & Tennen, 2007), which is defined as the ability that “focuses on how people 
use messages to generate meanings within and across various contexts, cultures, 
channels, and media” (Korn, Morreale, & Boileau, 2000) (p44). Indeed communication4 
                                                        
4 Unless otherwise specified, the general term “communication” has been used in this review to refer to interpersonal 




includes several aspects such as language, speech, and emotional processing, as well as 
social and environmental factors, and it has proved to be related to clinical outcomes in 
people with chronic illness in different contexts, such as familial relationships (Rosland, 
Heisler, & Piette, 2012) or patient-physician interaction (Ong et al., 1995). Moreover, in 
certain chronic conditions, supportive communication often represents the only possible 
form of intervention in terms of palliative care (Bury & Wood, 1979). 
In this perspective, a positive test for the Huntingtin gene and the development 
of symptoms leading to a diagnosis of HD certainly necessitate a series of adaptations on 
behalf of the individual – the successful navigation of which will affect longer term 
psychological adjustment.  However, for people with HD little research concerning this 
issue is apparent, especially with specific regard to communication, where the literature 
on people with HD appears to be largely dominated by studies on ‘objectively-observed’ 
medical and cognitive impairments, i.e. those assessed from a clinician’s perspective, 
including how they are affected by medical intervention and their neuroanatomical 
correlates (Henry, Crawford, & Phillips, 2005; Rusz et al., 2014; Teichmann et al., 2008). 
In addition, to our knowledge, no existing review has ever been conducted on the range 
of empirical studies on interpersonal communication in HD, and a clearer 
characterisation of the current corpus of evidence is warranted. As a consequence, the 
purpose of this review was to synthesise how communication is empirically 
conceptualised in research on people affected by HD, as well as provide an initial 
depiction of the epistemological and empirical heterogeneity of the research in this field, 






Aim and Design 
The primary aim of this review was to identify the elements of communication 
that have been investigated in empirical research with people with symptomatic HD by 
running a systematic search of relevant databases; the secondary aim was to capture and 
describe the variety of research perspectives and methods adopted. To fulfil these aims a 
scoping review was adopted. This allowed the use of a systematic and replicable search 
strategy without specifying a narrowly defined research question, as is usually required 
by systematic reviews (Arksey & O’Malley, 2005; Mays, Roberts, & Popay, 2001). The lack 
of sufficient research in more specific, narrower areas prevented this approach and 
instead the wider remit of a “form of knowledge synthesis that addresses an exploratory 
research question aimed at mapping key concepts, types of evidence, and gaps in research 
related to a defined area or field by systematically searching, selecting and synthesizing 
existing knowledge" (Colquhoun et al., 2014) (p. 1293-1294) was considered appropriate.  
Search Strategy and Inclusion Criteria 
A systematic search was performed up to January 31st 2015 using the following 
databases: PubMed, PsycINFO, and Linguistics and Language Behaviour Abstracts (LLBA). 
The date range searched started from 1 January 1993 since no genetically confirmed 
diagnosis of HD could be made before then. This is a common choice in recent reviews 
involving HD (Dumas et al., 2013; Franciosi, Shim, Lau, Hayden, & Leavitt, 2013; Henley 
et al., 2012). MeSH and Subject Terms were used for PubMed and PsycINFO respectively. 




was used to run a search through all the database fields. See Table 1 for details of the 
research terms used with each database. 
In order to be included in this review, studies had to be related to any of the 
different features of interpersonal communication in people with HD. Interpersonal 
communication was defined as the ability that “focuses on how people use messages to 
generate meanings within and across various contexts, cultures, channels, and media” 
(Korn et al., 2000). Therefore, studies referring to types of communication other than 
interpersonal (e.g., communication between cells) or focused on communication in 
people without HD (e.g., from a clinician’s or carer’s perspective) were excluded. Given 
the scoping nature of the review, a variety of methods were included – ranging from cross-
sectional and longitudinal designs to qualitative investigations. The participants of the 
studies had to have a diagnosis of HD confirmed by genetic testing. Since the focus of the 
review was on symptomatic HD patients, studies focusing only on presymptomatic 
participants were not included. 
Selections of Studies  
The initial searches across PubMed, PsycINFO and LLBA identified 478 citations. 
See Table 2 for details of the citations identified by each of the single databases. 250 
citations were subsequently excluded as duplicates or studies published before 1993. The 
title and the abstract of each of the remaining 228 citations were examined to assess the 
relevancy of the studies according to the aforementioned inclusion criteria. When the title 
or the abstract were not sufficient to assess relevancy, the full text of the citations was 
obtained. The reference lists of the studies included in the final selection were also hand 




studies were identified as relevant for the purposes of this review. See Figure 1 for a flow 
diagram of the study selection process. 
Results 
Categorization 
Out of the 65 studies that met the inclusion criteria for this review, four main 
general categories were identified that reflected the main research topics: 
Communicative Skills (5), Emotion (19), Language (35), and Speech (6). These categories 
were formulated on the basis of the most common categorisations currently adopted for 
describing the broad verbal and nonverbal components of communication (Knapp & Daly, 
2011). .Subcategories were also identified for every topic (see Table 2). The results for 
each category are discussed below. For full details on all the studies identified by this 
review please refer to Table 3. 
 
[Figure1 near here] 
 
Communicative Skills 
The main adopted methods in the Communicative Skills category included 
qualitative interviews and videotaped conversations, to investigate the perspective of 
people with HD on their communicative abilities. A number of social and environmental 
factors were found to play a relevant role in facilitating or complicating communication. 




having fewer people to talk with, while communication appears to be positively affected 
by sensations of safety, having the opportunity to speak for a longer time and the 
perception of support and adjustment from the conversation partner (Hartelius, Jonsson, 
Rickeberg, & Laakso, 2010). Similar results (Power, Anderson, & Togher, 2011) were 
reported when applying the WHO International Classification of Functioning, Disability 
and Health (ICF) (WHO, 2001). 
The adoption of Talking Mats™ (Murphy & Cameron, 2006) – an augmentation 
technique based on textured mats and sets of pictures showing different discussion topics 
– proved to significantly increase the effectiveness of communication in both dyadic 
(Ferm, Sahlin, Sundin, & Hartelius, 2010) and group interactions (Hallberg, Mellgren, 
Hartelius, & Ferm, 2013) with people affected by HD. Similar improvements were 
reported with the adoption  of a therapeutic approach based on linguistic and cognitive 
supplementation strategies (Klasner & Yorkston, 2001). 
Emotion 
The adopted methods in the Emotion category included the assessment of 
emotional processing, general neuropsychological evaluations and neuroimaging 
techniques. A general impairment in emotion expression was found in people affected by 
HD when compared to controls, especially in the expression disgust, fear, and sadness 
(Trinkler, de Langavant, & Bachoud-Levi, 2013). This was also highly correlated to an 
impairment in emotion recognition. A selective deficit for disgust was reported for 
spontaneous and posed expressions (Hayes, Stevenson, & Coltheart, 2009). The ratings of 
subjective emotional experiences elicited through affective scenes showed that people 




positive bias for neutral scenes (Ille, Holl, et al., 2011); however, a similar study failed to 
report any differences with the control group (Ille, Schäfer, et al., 2011).  
Labelling or rating tasks based on emotional facial expressions - such as the 
Ekman Pictures of Facial Affect (POFA) (Ekman, P., Friesen, 1976) - were adopted by the 
vast majority of the studies assessing emotion recognition, while other methods included 
self-report emotion ratings (Hayes, Stevenson, & Coltheart, 2007; Sprengelmeyer et al., 
1996) and custom recognition tests  based on olfactory and auditory tasks (Calder et al., 
2010; Hayes et al., 2007; Rees et al., 2014; Robotham et al., 2011; Sprengelmeyer et al., 
1996).  The majority of the studies on emotion recognition (12/18) found a significant 
impairment involving the recognition of negative emotions (sadness, fear, anger and 
disgust). A selectively more severe impairment for the recognition of disgust was also 
reported in some instances (Hayes, Stevenson, & Coltheart, 2009; Hayes et al., 2007; 
Sprengelmeyer et al., 1996; Trinkler et al., 2013; Wang, Hoosain, Yang, Meng, & Wang, 
2003). Other studies, however, did not find any selective impairment of disgust and 
observed in some cases that the impairment extended to positive emotions as well as 
neutral expressions (Labuschagne et al., 2013; Robotham et al., 2011; Snowden et al., 
2008). Other findings reported a predominant impairment for negative emotions other 
than or along with disgust, such as fear (Hayes et al., 2009; Milders, Crawford, Lamb, & 
Simpson, 2003a; Robotham et al., 2011; Snowden et al., 2008) and anger (Calder et al., 
2010; de Gelder et al., 2008; Henley et al., 2008; Robotham et al., 2011; Scharmüller et al., 
2013). The neuroanatomical findings associated with such impairments included reduced 
activity in both subcortical and cortical regions in general (Dogan et al., 2014), and in 




gyri (Scahill et al., 2013), insula, prefrontal cortex and hippocampus (Ille et al., 2011), as 
well as the cerebellum Scharmüller et al., 2013.  
The impairment for negative emotions was also found to differ across both 
different modalities and different emotions (e.g., HD closer to controls’ performance in 
recognizing anger through vocal stimuli; Rees et al., 2014). Moreover, when investigating 
emotion recognition through nonverbal stimuli based on body language, a predominant 
impairment with angry and emotionally neutral instrumental body postures (i.e., pouring 
water into a glass) was found (de Gelder et al., 2008). 
Language 
The adopted methods in the Language category ranged between general 
neuropsychological assessments of cognitive functioning, assessments of language alone, 
and conversation analysis approach, with both cross-sectional and longitudinal designs.  
Comprehension appeared to be generally impaired in HD for complex discourses 
when compared to controls (Saldert et al., 2010), although no correlation was found with 
the progression of the disease, except for the comprehension of metaphors. Other 
observed impairments included comprehension of past tense verbs (Longworth, Keenan, 
Barker, Marslen-Wilson, & Tyler, 2005), comprehension of sentences (Sambin et al., 
2012), phoneme discrimination (Teichmann, Darcy, Bachoud-Lévi, & Dupoux, 2009), rule 
application (Teichmann, Dupoux, Kouider, & Bachoud-Lévi, 2006), as well as word and 
rule learning (De Diego-Balaguer et al., 2008). When compared with people affected by 
Parkinson’s disease, the comprehension of participants with HD was found to be 
qualitatively and quantitatively similar in terms of comprehension impairments (Murray 




General neuropsychological investigations (which included language subtests) 
were performed in many studies adopting broad batteries, such as the Repeatable Battery 
for the Assessment of Neuropsychological Status (RBANS; Randolph, 1998), as well as 
single function tools like the Boston Naming Test (BNT; Kaplan, Goodglass, & Weintraub, 
1983), and phonemic and semantic fluency tasks. Semantic and phonemic fluency, 
naming, and comprehension were found to be generally impaired in cross-sectional 
studies (Arango-Lasprilla et al., 2006; Begeti et al., 2013; Duff, Beglinger, Theriault, 
Allison, & Paulsen, 2010). The impairment on verbal fluency was found to be predicted by 
structural alterations on the caudate nucleus and the putamen (Backman, Robins-Wahlin, 
Lundin, Ginovart, & Farde, 1997). The same impairment was also reported at baseline in 
longitudinal designs; however no significant change in language was found across the 
follow-ups (Beglinger et al., 2010; Lemiere, Decruyenaere, Evers-Kiebooms, 
Vandenbussche, & Dom, 2004). Moreover, a study adopting event-related potentials 
(ERPs) found significantly longer latency times in HD when investigating language 
production (Munte et al., 1997). 
In terms of language production, significant impairments were generally found 
for both phonemic and semantic fluency (Monsch et al., 1994; Rosser & Hodges, 1994; 
Troster et al., 1998; Chenery, Copland, & Murdoch, 2002; Lepron, Peran, Cardebat, & 
Demonet, 2009), sometimes with a predominant deficit for the semantic variant (i.e., 
generation of words from a category) (Barr & Brandt, 1996) or the phonemic one (i.e., 
generation of words from a letter) (Taylor, Salmon, Monsch, & Brugger, 2005). However, 
an improved performance was reported with the use of cued stimuli (Christopher 
Randolph, Braun, Goldberg, & Chase, 1993). The performance on verbal fluency was also 




velocity Deckel & Cohen, 2000), as well as lack of activation of the left inferior temporal 
gyrus (Lepron, Peran, Cardebat, & Demonet, 2009).  
A number of studies found no overall significant impairment in HD in terms of 
lexical-semantic descriptive abilities of people with HD, except an increased number of 
grammar errors (Jensen, Chenery, & Copland, 2006; Murray & Lenz, 2001). However, 
another investigation did report a deficit of lexico-semantic abilities, along with an 
impairment on the interpretation of ambiguous meanings (Chenery, Copland, & Murdoch, 
2002). Other observed impairments of language production included a significant deficit 
of application of grammatical rules (Teichmann et al., 2005, 2008), especially in relation 
to past tense rule use (Longworth, Keenan, Barker, Marslen-Wilson, & Tyler, 2005; Ullman 
et al., 1997), which appears to be relarted to specific striatal subregions  (Teichmann et 
al., 2008).  
Interestingly, a case study that reported  the presence of anomia (difficulties 
retrieving names), reduced comprehension, and echolalia (automatic repetition of 
vocalizations) in a participant with HD also  found that the latter impairment was actively 
used by the patient as a compensatory strategy to enhance conversational participation 
(Saldert & Hartelius, 2011).  
Speech  
The most adopted method in the Speech category was Acoustic Voice Analysis, 
i.e. a group of techniques assessing several features of voice such as syllable length, vowel 
duration, accent production, and phonation time. Observed impairments in people with 
HD included pitch and loudness (I Hertrich & Ackermann, 1993), utterance duration (Ingo 




García et al., 2011). Significantly worse impairments were reported in HD ion syllable 
duration when compared with other neurological conditions, such as Parkinson’s disease, 
Friedreich’s ataxia, and pure cerebellar syndrome (Ackermann, Hertrich, & Hehr, 1995). 
Moreover, as the impairments were in some cases positively correlated with the severity 
of the disease, the hypothesis of the adoption of a speech acoustic marker to mark the 
onset of HD was put forward (Velasco García et al., 2011; Vogel, Shirbin, Churchyard, & 
Stout, 2012). Promising results were also found by a single group pre-test post-test study, 
based on a month of daily speech therapy sessions on phonation, respiration, and labial 
and lingual movements that showed to significantly improve cranial nerves assessment 
scores and swallow functioning (Giddens, Coleman, & Adams, 2010). 
Discussion  
Summary of Main Findings 
In this review empirical studies were searched to identify the features of 
communication that have been investigated to date. The most adopted investigation 
methods were visual recognition tasks of emotional pictures, cognitive language 
examinations, and acoustic voice analysis. Very few studies focused on therapeutic 
interventions on communication or speech, often with a single case design (Ferm et al., 
2010; Giddens et al., 2010; Hallberg et al., 2013; Klasner & Yorkston, 2001). Other much 
less investigated elements of communication included emotion expression and language 
comprehension. Despite the general focus of this review, the most neglected category was 
Communicative Skills, with only two studies focussing on their assessment, primarily 
through qualitative interviews and focus groups. However, this underrepresentation in 




general tendency in all those chronic illnesses which feature communicative 
impairments, such as stroke, Parkinson’s disease, and motor neuron disease (Mistry & 
Simpson, 2013; Thorne et al., 2002). This may be partially explained by the frequent co-
occurrence of speech and cognitive impairments, which could confound the patients’ 
understanding of their own communicative abilities.  
Many studies  compared people with symptomatic HD with people with other 
neurological disorders (Ackermann et al., 1995; Arango-Lasprilla et al., 2006; Barr & 
Brandt, 1996; Chenery, Copland, & Murdoch, 2002; Jensen et al., 2006; Longworth, 
Keenan, Barker, Marslen-Wilson, & Tyler, 2005; Monsch et al., 1994; Murray, 2000; 
Murray & Lenz, 2001; Murray & Stout, 1999; Peran, Demonet, Pernet, & Cardebat, 2004; 
Possin et al., 2005; Christopher Randolph et al., 1993; Rosser & Hodges, 1994; Snowden 
et al., 2008; Taylor et al., 2005; Testa et al., 1998; Troster et al., 1998; Ullman et al., 1997; 
Wang et al., 2003) or premanifest HD (Begeti et al., 2013; Henley et al., 2008; De Diego-
Balaguer et al., 2008; Labuschagne et al., 2013; Lemiere et al., 2004; Milders, Crawford, 
Lamb, & Simpson, 2003b; Scahill et al., 2013; Velasco García et al., 2011; Vogel et al., 2012). 
However, only 21 studies out of 65 included specific information concerning the stage of 
the disease for each of the participants with manifest HD. The results of the comparisons 
with other neurological conditions normally vary upon the conditions themselves, and 
can be useful to better understand the role of neuroanatomical structures in the genesis 
of the disorders. The general conclusion from comparative studies with premanifest HD 
was that many of the cognitive and communicative impairments observed in symptomatic 
HD may show a much earlier onset than motor difficulties, thus starting to affect patients’ 




the results of the PREDICT-HD cohort study,  are coherent with the proposal for new 
broader and more flexible diagnostic criteria for HD (Loy & McCusker, 2013).  
In terms of augmentation of communication, the adoption of Talking Mats™ and 
linguistic and cognitive supplementation strategies have yielded provisional positive 
results, helping people with HD to create or improve their coping and compensation 
strategies.  
Despite the general lack of literature, the findings of the investigations of 
communication from the perspective of people with HD looked seminal in shedding a 
preliminary light on the influence of social and environmental factors on communication, 
such as the type of interlocutor, the amount of time allowed for conversations and the 
presence of a strong support from relatives and carers. However, many of these aspects 
(e.g., the nonverbal features of communication) are yet to be fully investigated.  
The inconsistency of the findings on emotion expression makes it difficult to draw 
any conclusions about the impact of HD on the ability to convey emotional messages.  This 
is likely to be due to the fact that the studies adopted diverging methods to conceptualize 
emotion expression (e.g., subjective intensity rating VS objective expression judgement). 
Moreover, the adoption of only pictorial visual stimuli leaves unanswered the question as 
to whether dynamic images would trigger different performances in emotion expression. 
Another limit in the results is the absence of stimuli for sadness, surprise and anger in 
some of the adopted assessment tools, as well as the lack of stimuli for the expression of 
emotional body language in general.    
A deficit of recognition of negative emotions, which has been widely noted in the 




However, the results are not clear whether the impairment can be selective for disgust, as 
it has been often reported in previous studies (Henley et al., 2012) since specific deficits 
were also found for other emotions (e.g., anger and fear), in some cases (Labuschagne et 
al., 2013; Robotham et al., 2011; Scharmüller et al., 2013; Snowden et al., 2008) even 
without a concomitant deficit for disgust itself. Despite a general predominance of the use 
of visual methods for the assessment of emotion recognition and a relative homogeneity 
between them (i.e., often based on emotional picture labelling), this inconsistency among 
the performances may be due to the variation between similar tasks involving the same 
sensorial modality, as well among the few ones investigating different modalities, such as 
auditory or olfactive tasks. Indeed, certain stimuli may elicit more than one negative 
emotional response (e.g., both sadness and fear or fear and disgust) as well as elicit 
ambiguous responses that cannot be categorised properly. This appears to be particularly 
relevant for emotional responses based on body language, where disgust and fear tend to 
share the same kind of reaction (i.e., moving backward whilst putting hand palms 
forward; de Gelder et al., 2008) However, the data on body language responses are still 
quite sparse, and in this review only one study investigated their recognition. 
Impairments of numerous domains of language, such as discourse 
comprehension, phonemic and semantic fluency, naming, picture description and 
syntactic abilities, were reported. This was particularly clear across all the cross-sectional 
studies, while the data appears to be more controversial in the fewer studies that adopted 
a longitudinal design, which often showed no significant changes in language over the 
period of years. Moreover, the vast majority of studies on language production focused on 
word retrieval; this leaves a gap in the investigation of the extent and variability of other 




of these impairments on conversational abilities. From this perspective, a single case 
study appears to suggest that deficits such as echolalia may be occasionally exploited by 
affected individuals as a compensation strategy to improve participation in 
conversations. This accords with a recurrent topic in clinical neuropsychology, i.e. that an 
impaired test result does not always reflect a functional impairment, as it is not often easy 
to distinguish between signs of impairment and signs of functional compensation (Leiwo 
& Klippi, 2000). 
Finally, the findings showed that HD has a significant impact on features of speech 
such as pitch, phonation and loudness. However, promising results were reported for 
speech therapeutic interventions (Giddens et al., 2010). Perhaps most importantly, the 
observed impairments showed a tendency to correlate with the progression of the 
disease, leading to the hypothesis of a speech acoustic marker of disease onset. Yet again 
no study focused on the impact of these impairments on communication of both people 
affected by HD and close family and friends. 
Limitations, Future Directions, and Implications for Clinical and 
Rehabilitative Practice 
When considering the results of the present review, a potential limitation could 
be represented by the necessity of excluding all the citations published prior to the 
introduction of genetic testing in 1993. However, this exclusion currently represents a 
standard in research on HD, as demonstrated by its adoption by a number of recent 
reviews (Dumas et al., 2013; Franciosi et al., 2013; Henley et al., 2012). 
Several directions for future research have emerged from the conclusion drawn 




increase in the number of studies adopting longitudinal designs in order to track the 
changes in communication throughout the whole progression of the disease. This is also 
compatible with the need for more comprehensive and precise information regarding the 
stage of disease of the participants included in the samples, as well as a deeper 
understanding of the several variables that can affect communication directly or 
indirectly, such as social issues, family support or medical treatment. Moreover, even 
though many studies included some kind of baseline neuropsychological assessment, the 
need exists for a more systematic inclusion of assessments of any possible variables that 
may affect communicative performances due to cognitive deterioration – such as aphasia, 
working memory functioning and deficits involving attention, visuo-spatial and executive 
skills – as well as motor impairment.  
It is also apparent the need for further research characterised by a deeper focus 
on the subjective experience of affected people and their close relatives, and a more 
comprehensive coverage of the multiple features of communication. The same need exists 
for studies investigating the mechanisms involved in the way people with a diagnosis of 
HD communicate emotionally, as well as a focus on emotion recognition through different 
modalities. Moreover, as suggested by the limited evidence retrieved by the review, the 
heterogeneous nature of this construct is likely to be more efficiently understood through 
the adoption of diverse methods, ranging from subjective measures of emotional 
effectiveness, appropriateness, and intensity to objective evaluations performed by 
independent observers.  
Finally, very little is known concerning the effect of the impairments of language, 
speech or emotion on the functional communicative capacity of people affected by HD and 




verbal communication can lead to inaccurate clinical assessments due to the inability of 
the patients to express their needs or comprehend the demands of their clinicians or 
carers. This can be also exacerbated by the combination of expressive aphasia and 
dysarthria that is often observed in HD due to involuntary movements and cognitive 
deterioration. Moreover, difficulties in emotional communication, both in terms of 
expression and recognition or empathy, can lead to problems similar to those observed 
with poor verbal communication, such as misunderstandings, feelings of awkwardness, 
and frustration. Moreover, the subtler and less evident nature of emotional difficulties (as 
compared to language impairments), may also trigger important social consequences, 
such as the development of avoidant behaviour, a further overall deterioration of 
interpersonal interactions – as observed with alexithymia (Spitzer, Siebel-Jürges, Barnow, 
Grabe, & Freyberger, 2005) – and the potential for social discrimination and stigma.  
Therefore, a more complete understanding of these constructs is required, possibly 
through the adoption of a variety of methods – including longitudinal designs and the 
investigation of a wider range of verbal, emotional and social components of 
communication – in order to monitor the subjective and objective experience of people 
with HD over the different stages of the disease. This will bring the overarching potential 
to help inform new intervention strategies, refine current clinical approaches, as well as 
improve patients’ relationships with their caregivers and clinicians. 
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Database search details. 
Database Search terms Citations 
PubMed "Huntington Disease"[Mesh] AND "Communication"[Mesh] 262 
("Huntington Disease"[Mesh]) AND "Language"[Mesh] 100 
PsycINFO DE "Huntingtons Disease" AND DE "Communication" 16 
DE "Huntingtons Disease" AND DE "Language" 11 
LLBA "Huntington’s" 89 
Note: No Subject Term for HD was available in LLBA, therefore the general keyword "Huntington’s" was 
searched through all the database fields. 
 
Table 2  
Distribution of citations among categories and subcategories. 
Category Subcategory Partial citations Total citations 
Communicative Skills Assessment 2 5 
Augmentation 3 
Emotion Expression 4 19 
(3 overlapping) 
Recognition 18 
Language Comprehension 7 35 
(1 overlapping) Neuropsychological Investigations 7 
Production 22 
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Past tense word 
production and rule 
application tasks 
HD showing excess motor 
activity and past tense rule 
use. 










Analysis of timing, 
frequency and 
intensity  
HD significantly impaired 
in speech rate. Pre-HD not 
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Relevant findings Stage Age 
(SD) 
Gender 
Ctrl (15) tendency to significance. 
Hypothesis of speech 
acoustic marker for 
diagnosis of HD.  















Perception of gender, 
age & gaze direction 
BFRT 
Perception of basic 
emotions 
HD generally impaired on 
emotion recognition, with 
specific severe impairment 
for disgust.  
Note: ACE-R = Addenbrooke’s Cognitive Examination-Revised; AD = Alzheimer’s Disease; ADP = Aphasia Diagnostic Profiles; AIDS = Assessment of Intelligibility of 
Dysarthric Speech; BD = Brain Damaged; BEES = Balanced Emotional Empathy Scale; BFRT = Benton Facial Recognition Test; BNT = Boston Naming Test; CBF = 
Cerebral Blood Flow; CBV = Cerebrovascular condition; CETI = Communication Effectiveness Index; CG = Caregiver; CVLT = California Verbal Learning Task; D-HD = 
Demented HD; DCT = Discourse Comprehension Test; EEFC = Effectiveness Framework of Functional Communication; ERP = Event Related Potentials; FA = 
Friedreich’s Ataxia; FAD = Familial AD; FAS = Letter Fluency Test; FEEST = Facial Expressions of Emotion: Stimuli and Tests; FM = Family Member; FTD = Fronto-
temporal Dementia; HCD = Hat-Cat-Dog task; HD = Huntington’s disease; IAPS = International Affective Picture System; fMRI = functional Magnetic Resonance Imaging; 
IRI = Interpersonal Reactivity Index; KDEF = Karolinska Directed Emotional Faces; MRI = Magnetic Resonance Imaging; ND-HD = Non-Demented HD; NR = not 
reported; NS = Non-thalamic Subcortical Stroke; PA = Posterior Aphasia; PCS = Pure Cerebellar Syndrome; PET = Positron Emission Tomography; PSP = Progressive 
Supranuclear Palsy; QADS = Questionnaire for the Assessment of Disgust Proneness; RBANS = Repeatable Battery for the Assessment of Neuropsychological Status; 
RPS-Form = Rehabilitation Problem Solving-Form; TAS20 = Toronto Alexithymia Scale; TLC-E = Test of Language Competence – Expanded Edition; TM = Talking Mats; 
VD = Vascular Dementia; TOMWK = Test of Word Knowledge; TWT-R = The Word Test – Revised; VBM = Voxel Based Morphometry; VHI = Voice Handicap Index; VOT 
= voice-onset-time; WAB = Western Aphasia Battery; WAIS = Wechsler Adult Intelligence Scale; WD = Wilson’s Disease; WHO ICF = World Health Organization 
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Abstract 
Objectives: This study explored the perspectives of people affected by 
Huntington’s disease on their own communicative abilities. 
Methods: Qualitative semi-structured interviews were carried out with 8 people 
with early HD. The data were analysed through thematic analysis.   
Results: Four themes were constructed from the data, characterised by the 
following core topics: How HD directs and mediates communication; Regaining 
control to improve communication; Emotional outflows into communication and 
the struggle for separation; Sheltering as a way to boost confidence in 
communication  
Discussion: Separating patients’ identity as individuals from that of a person with 
a disease can help increase communicative control. Consistent with the general 
theory and model of self-regulation (SRM), patients should be allowed a wider 
range of choices to regain control over communication. Achieving better emotion 
regulation is of paramount importance for communication, and factors such as 
medication regimes, relationships and existing coping strategies should be 
strengthened. Consistent with previous research, feelings of safety and the idea of 
a safe place (‘sheltering’) represent an effective coping mechanism. Practical 
implications include the refinement of communication and relationships among 
clinicians, caregivers, and patients with HD by considering a wider range of 
medical, psychological and socio-environmental factors. 
Keywords: Huntington's disease; communication; emotion regulation; thematic 
analysis; patients' perspectives.  
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Introduction 
Huntington’s disease (HD) is a hereditary chronic neurodegenerative 
disorder which affects 10-12 people per 100,000 in the western world.1 Typical 
symptoms include involuntary movements (chorea), cognitive deterioration, 
psychological difficulties, and psychiatric disorders.2 Since the transmission 
mechanism is autosomal-dominant, affected individuals have a 50% probability of 
transmitting it to their children (usual age of onset is 40-50 years). The mean life 
expectancy after the diagnosis is typically 20 years3. Genetic testing is available for 
individuals at risk, allowing them to know if they carry the disease gene before the 
onset of symptoms. All individuals with the gene without symptoms 
(‘presymptomatic’ people) will develop the disease.  
Many cognitive impairments have been reported in people with HD, 
including problems with all aspects of communication. Communication is 
understood in this context as a multifaceted ability that investigates how people 
create meanings through messages transmitted across various channels, media 
and contexts,4 and includes elements of language, speech, as well as emotion and 
social abilities.  Regarding more specific aspects of communication, speech 
production is often impaired and starts to deteriorate before comprehension,5 and 
the spontaneous initiation of conversations is reduced.6 Research on nonverbal  
communication, such as body language and emotional processing, is less frequent 
in HD,  with the exception of emotion recognition.7 In this respect studies have 
indicated that all these components can be affected by the disease.8 In addition, HD 
can also negatively affect the ability to comprehend and reflect on the mental 
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states of oneself and others (i.e., theory of mind9), which plays a fundamental role 
in communicative competence, especially through the attribution of intentions.10  
Nevertheless, the current literature on communication in HD appears to 
be mainly characterised by quantitative studies focused on the observation of 
medical and cognitive impairments,11 with a tendency to prioritise the 
perspectives of clinicians.12–14 The investigation of the perspectives of people with 
HD on their own communication abilities is generally much rarer and only recently 
has an interest started to emerge in communication as a phenomenon that 
embraces social skills and interactions, and not just the traditional underpinnings 
of language and speech.15 Indeed, even when patients’ perspectives on the general 
impact of the disease have been investigated, data analysis falls more in the 
quantitative category, with greater focus given to the frequency of reoccurrence of 
themes rather than a qualitative exploration of patients’ narratives themselves.16 
On the other hand, to our knowledge only two studies have so far used a qualitative 
approach to investigate communication in HD.  
Hartelius and colleagues17 adopted individual interviews and focus 
groups to triangulate the information between people with HD, family members, 
and caregivers, finding that a number of social and environmental factors play a 
relevant role in complicating communication. These included the speed of 
conversations or having fewer people to talk with, while a positive impact was 
reported for sensations of safety, having the opportunity to speak for a longer time, 
and the perception of support and adjustment from the person with whom they 
were speaking. However, the thematic analysis was characterised by a very 
descriptive approach, and the interviews did not include any questions on 
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nonverbal aspects of communication. In the second study conducted, Power, 
Anderson and Togher18 carried out a single case analysis with a man with 
advanced-stage HD and also found that supporting social and environmental 
factors can have a positive impact on communication. However, their approach 
(content analysis) offered a useful but predominantly descriptive report and did 
not allow for a more in-depth interpretation of meanings, as well as omitting 
nonverbal elements of communication such as emotional processing.  
Therefore, considering the current gap in the literature, the research 
question addressed by this study was the exploration of how people affected by 
HD make sense of their communication experience with others.      
Methods 
Methodological approach 
A qualitative design was adopted, based on semi-structured interviews 
analysed through thematic analysis (TA). We selected TA for its recognised 
usefulness within the field of psychology and communication disorders,19 and its 
ability to allow for the usage of both deductive (i.e., theory-driven) and inductive 
(i.e., data-driven) analyses of the themes identified within the interviews.20  
Sampling   
People affected by Huntington’s disease were invited via post across the 
North West of England by the Huntington’s Disease Association (HDA). Of the 
people who expressed their interest, eight participants with symptomatic HD were 
considered eligible. The inclusion criteria included being aged 18 or more, being 
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able to be interviewed in English and being symptomatic at an early or moderate 
stage of disease. This limit was due to the difficulties in attending personal 
interviews that arise in the later stages of HD. As the study focused on the impact 
of the disease on patients’ communicative experiences, we did not include any pre-
symptomatic individuals. See Table 1 for the demographic details of the 
participants.  
Procedure 
Individual semi-structured interviews were carried out face to face with 
the participants at a time and place convenient to them (usually their home). We 
selected this approach to allow the in-depth exploration of relevant themes as well 
as to ensure that all participants felt comfortable and had all the assistance they 
might need.21  The length of the interviews ranged from 40 to 60 minutes (M = 45). 
Most of the participants reported to feel more comfortable if a  caregiver (e.g.,  
their partner) was allowed to be present during the interviews. Since our main aim 
during the data collection was to make the participants as comfortable as possible, 
this request was always facilitated. However, the caregivers were asked not to 
contribute in any way and any comments they made did not form part of the data 
collection. Moreover, in order to guarantee a minimum impact on the interviewing 
process, the caregivers were asked to sit in a position which limited any verbal and 
nonverbal interferences (e.g., out of the participants’ direct eye contact).  We 
structured the interviews according to a framework consisting of four general 
topics: Verbal Communication, Nonverbal Communication, Mediators of 
Communication, Contexts of Communication. The topics were based on some of 
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the most common categorisations of communication dimensions22 and to be as 
broad and yet comprehensive as possible. 
Data analysis  
All the interviews were transcribed verbatim and analysed using thematic 
analysis (TA).  The six steps outlined by Braun and Clarke19 were used as a guide 
to analysis.  
Ethics approval 
This study was reviewed and approved by the Faculty of Health and Medicine 
Research Ethics Committee at Lancaster University (ref: FHMREC14026).  
Results 
Identified codes and themes 
Following familiarisation with the whole dataset, 73 codes were 
generated. These were then collated to six initial candidate themes. Upon further 
revision, the final code list was reduced to a total of 36. Out of these, four final 
themes were identified that were distinctive in their own right, as well as coherent 
with the broader scheme of the analysis and relevant to the research question. See 
Table 2 for the final theme list and breakdown into the respective codes.   
“You ever wanna say things to people, but you can’t”: how HD directs 
and mediates communication 
All the participants agreed that HD plays an important role in their 
communication with others. In fact, they made sense of their communicative 
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difficulties by seeing HD as the main cause and this expressed itself both directly 
and indirectly. Directly, the participants saw HD as an external agent that actively 
blocks their communication: 
 “I think it is a funny illness, but affects you in different ways. […] you ever 
wanna say things to people, but you can't. Because it feels there's 
something wrong, with your illness. […] You want to say things, but you 
can't!” (Participant 3) 
The effects of HD can present in many different ways, starting from speech 
and language. Problems with articulating words, controlling voice speed, or 
respecting conversational roles were frequently reported and disrupted verbal 
communication at its core:   
“I probably speak fast. And also not loud enough. Sometimes I have to 
speak twice. I probably do articulate a bit harder. […] I don't use many 
long words now, where I used to. I used to bullshit to heaven, but now I 
don't.” (Participant 7) 
The cause of these difficulties was entirely attributed to HD, which the 
participants perceive as the external reason they felt and behaved the way they 
did. In this perspective, HD acts as director of the participants’ communication, 
taking control over their active role in everyday interactions by drastically 
decreasing their communicative repertoire. As some of them pointed out: 
“You don't speak to people... the illness makes you feel that way, even 
though you're trying to speak to people.” (Participant 3) 
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However, the influence of HD on communication is not confined to its 
most apparent manifestations, such as articulation impairments. Indeed, many 
related difficulties such as feelings of constant fatigue, memory problems, and 
attentional drops can indirectly affect the participants’ communicative experience. 
Although not strictly related to the verbal side of communication, these problems 
ultimately play an important role in participants’ everyday life by undermining 
their ability to interact with people or read situations:  
“I like speaking with my son, I just keep... running out of things to say, 
because I keep forgetting.” […] For example we go to my sister's for 
Christmas, and I was trying get involved but I just feel so stupid because I 
can't think, my memory is very random […] and it just adds more and 
more pressures because I start getting agitated with myself. […] It must 
be to do with HD… […] I don’t know what’s going on half of the time.”  
(Participant 4)  
 “The other thing that happens sometimes is that I can't think of a word 
to say next.” (Participant 8) 
Therefore, HD not only directly influences participants’ communication 
through its characteristic symptoms, but also subtly mediates it via less apparent 
yet related conditions that pull the strings of nonverbal interactions and greatly 
increase the effort involved in simple discourses. Just as for their verbal issues, 
however, the participants made sense of these mediational effects as an external 
source of discomfort due entirely to HD. Not surprisingly, the combination of these 
influences eventually led the participants to develop a reluctant attitude towards 
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communication. This particularly manifested through being quiet or avoiding 
situations in which communication is required:  
“I just can't be bothered, I just bugger off. I got a little scooter, so I just 
nip off to the quarry. […] I don't really bother that much talking. If it's not 
the neighbour then I wouldn't bother. Yeah, it's just a bit of an effort. […] 
I just say hello to acknowledge people.” (Participant 1) 
Again, it is worth noting how these behaviours were seen by the 
participants as due to the disease, to the extent of listing them among its stages 
and symptoms: 
“I don't really mean [to speak to people], because one stage of HD you 
don't intermingle with people, leave them on your own, if you will. I don't 
know if you know…” (Participant 4) 
Indeed, one of the participants mentioned being identified with HD by her 
parents, by having ‘the Huntington's face’: 
“They say… ‘you know, you look as you have Huntington’s’. I’ve got the 
face. The Huntington’s face. It’s just the expressions that my mum used to 
do with Huntington’s. And they say I look the same.” (Participant 6) 
Clearly, being identified this way can lead to significant difficulties in 
communication. From this perspective, the participants’ tendency to conceive HD 
as an external director and mediator may represent one of the causes of the 
‘fighting’ metaphors often used to describe their struggle with symptoms and their 
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consequent attempts to regain control over communication and prevent it from 
being incorporated into their own identity.  
Becoming a director again: regaining control to improve 
communication 
Of all the effects of HD on participants’ communication, the lack of control 
appeared to be perceived as one of the most substantial and, as mentioned, it 
manifested in several direct and indirect ways. However, it also seemed to drive 
the participants’ will to develop strategies to reacquire control over 
communication and become once again the real director of their daily interactions. 
For instance, all the participants claimed to find using the telephone much harder 
since the onset of the disease, due to the difficulties people had in understanding 
them. As a consequence, they started avoiding phone conversations, asking their 
carers or partners to intercede for them. However, this went beyond a mere 
avoidant behaviour, since it was often taken by the participants as an opportunity 
to shift the communication to more comfortable settings and modalities, like 
meeting in person or replying by email: 
“The phone is probably the most difficult one. […] I talk to people, but it's 
just the phone sometimes. I prefer to leave it. […] If somebody phones me, 
and I have to get back in touch with them, I just use text or an email. That 
type of thing.” (Participant 7)   
Texting was a popular choice for most of the participants, as it did not 
impose the same constraints as other communication methods in terms of time 
and effort. As Participant 4 noted:  
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“Texting! That's one thing that I can do! If I text people, they understand 
what I'm talking about!” (Participant 4) 
From this perspective, delegating phone conversations and switching to 
texting represent a good strategy to shift part of the burden of communication. 
This was even clearer when some of the participants claimed to prefer listening 
over talking. Well aware that communication consists of both sending and 
receiving, they appeared to have developed a preference for the latter: 
“I can still listen, you know what I mean. I prefer listening to speaking. I 
can understand what people are talking about, I can listen. If I'm going 
to a group or something, I sit and listen, and then... when I feel 
comfortable with people around me, then I can open up and I think that 
has to do with HD…” (Participant 4) 
This is probably due to how listening allows engagement in conversations 
without the amount of energy required by speaking. As Participant 5 noted: 
“I know when to chill out and I know when to use the energy. Like this is 
using more energy than I would normally. But tomorrow daytime I can 
relax and I've got a birthday party tomorrow night and I know I'm gonna 
use more energy for that, because I'll be seeing a lot of people and I'll be 
talking to a lot of people. (Participant 5) 
In addition, the management of these aspects of communication seems to 
benefit from an attitude of general openness towards HD and its effects. Indeed, 
many participants mentioned telling people about their condition, in order to 
prevent any distressing situations: 
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 “I'm more open. I know I can explain things to people. […] I do say to 
people 'look, if I sit with you, I know I might bump into you'. If I'm going 
out somewhere I'll sit at the end of the table. […] People understand. If 
I'm open about it, people understand.” (Participant 2) 
Openness, however, comes at the cost of potential misunderstandings, as 
reactions and interpretations may differ significantly among people: 
 “The worst thing people do, is tell people. As soon as you tell them. That's 
it. Bloody terrible. I've never done, I'd never tell anybody again, I've never 
advise anybody to tell anyone. 'Cause once you've told them, then you're 
not going to get employed or you're going to have a rough ride from then 
on.” (Participant 7) 
Thus, trying to be open to regain communicative control can backfire, by 
turning communication into a source of emotional discomfort.   
“One moment I’m fine, the next moment I’m not”: emotional outflows 
into communication and the struggle for separation 
One of the most challenging effects of HD was how it made emotions 
become unstable, and for many this was a new experience: 
“One moment I'm fine, the next moment I'm not. Different things upset 
me... I was at work, and there was this nurse, she was bossing me about, 
and I said you're being horrible to me […] and I got angry with her – never 
been like that before […] I was thinking 'what's wrong with me?' And she 
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said to me ‘what's wrong with you?’, I said "I don't know", I said I'm going 
to go and get tested. I may have Huntington's.” (Participant 6) 
Moreover, the emotional aspects varied significantly. For instance, 
Participant 5 mentioned getting progressively detached from her emotions: 
I used to watch telly and I used to cry at the drop of a hat, and I used to 
have a box of tissues next to me and be soppy at anything, and then now 
I'm not. That box of tissues can stay there for months *laughs*. […] I'm 
not as sympathetic as I used to. […] I can still get angry, but not as much. 
I'm becoming more and more apathetic. Definitely. (Participant 5) 
On the other hand, Participant 6 seemed to experience the opposite 
situation: 
I think I am sort of angry a lot more that I used to be, but I don't mean to 
be. […] I knew there was something wrong with me, snappy and shouting 
at people, and I thought that's not like me, because I don't shout. I do now. 
It's my Huntington's, I can't help it. (Participant 6) 
However, the actual effect perceived by affected individuals can be rather 
homogeneous, since the participants made sense of it as a general external 
influence beyond their control. As for speech and language, emotional issues were 
perceived as a symptom of the disease, rather than part of the psychological 
adjustment to the illness. As Participant 2 noted: 
“I think it was just the fact that... a symptom of the disease. As for 
depression.” (Participant 2) 
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Difficulties with emotions can become even more problematic when, as 
previously mentioned, distressing emotional situations may arise while trying to 
be open about HD and regain control over communication. Although openness and 
control can promote illness acceptance (which is considered of primary 
importance in psychological adjustment to chronic illness23,24), those emotional 
experiences took a major toll on the participants, ultimately leading them to 
perceive their emotional and communicative life as a source of unsteadiness that 
frustrated any attempts at accepting their condition: 
“With this illness, even though I accept it, it's very hard to accept things. 
I cannot drive anymore, and that's what I loved. I loved to drive all the 
time. All the sport's gone…” (Participant 4)  
“I'm good at crying... I think I've got a little more sad. I started to be sort 
of thrown off without sense. I think when you have to be strong every day, 
sometimes it is hard...” (Participant 8) 
One of the ways to manage their communication and ultimately promote 
illness acceptance was for the participants to learn better how to regulate their 
own emotions. However, with the participants, emotion regulation seemed to 
happen at the cost of engaging with extremely difficult and fundamentally 
disturbing thoughts, which led them to deal with challenging emotional outflows 
into their communicative experience. As Participant 4 mentioned: 
“The thing with HD, I've noticed, if I am aggravated or someone else is 
aggravated or agitated, it takes some 5 or 10 minutes to me to calm 
down, but with HD it has a knock-on effect so it's like taking 3 times as 
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long for me just to calm down because I go up on it, got more and more 
to think about and it drives me crazy.” (Participant 4) 
The process of achieving a better level of separation between 
communication and emotions clearly plays a pivotal role from this perspective. 
Yet, this can prove to be a very long and painful path, characterised by pervasive 
feelings of anxiety and instability that can turn communication into both a benefit 
and a liability, a ‘double-edged sword’: 
“I know it's important to talk to people, but when everybody comes 
around to see me, I just feel a bit nervous about talking. And I think it 
must be the illness, Huntington's, making me feel like that way. But I don't 
mind people talking about my illness to people, so it's a double-edged 
sword.” (Participant 3) 
However, whereas such a separation is achieved, emotion regulation has 
a clear beneficial effect. In the case of the participants, it promoted healthy 
grieving, helped them to better accept their condition, and ultimately improved 
their communication: 
“I think I got better, 'cause I've grieved for what I've lost. So I accepted 
that. 'Cause a couple of years ago, I'd go into a shop and say ‘I've got 
Huntington's' and I'd cry my eyes out. I've come to terms with it.” 
(Participant 1) 
Although long and challenging, the process of regulating emotions was 
seen to be promoted by a number of medical and psychosocial factors. For 
instance, all the participants agreed on the paramount importance of medication:  
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 “I was just tired and couldn't be asked to do things, you know. But now, 
once I started to take Citalopram I felt so much better in myself, it really 
lifted me up.” (Participant 2) 
In certain cases, being prescribed the appropriate medications could even 
benefit communication directly: 
 “I've got my medications now I'm fine. […] I wouldn't even be able to 
speak if I didn't take them.” (Participant 6) 
A similar beneficial effect was also mentioned for social and 
environmental factors. In particular, having a close family and friends around 
allowed the participants to feel more comfortable about communication, as well 
as safer when coping with daily situations by being able to ask for help when 
needed: 
 “I do feel more comfortable here, you know like if you have people 
around, I'm fine. […] I'm alright with going to different places. Well, I do 
try to, I like to try different restaurants and stuff like that, which I've 
already done. That hasn't gone yet. And we do have people round for 
meals and stuff like that.” (Participant 7) 
It is also important to notice how the positive relationship between 
emotion regulation and communication is bidirectional: just as regulating 
emotions can improve communication, so communicating better can promote 
emotion regulation; similarly, better relationships can improve both emotion 
regulation and communication – and vice versa. Thus, the successful expression 
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and reinforcement of these factors allowed for a virtuous circle to come into being, 
which considerably improved the participants’ quality of life. 
“I go back into my little world”: sheltering as a way to boost 
confidence in communication 
Another beneficial factor that emerged from some interviews was the idea 
of having a personal safe place where the participants could take shelter. Initially, 
this idea appeared to be mainly identified with a feeling of preference and 
protection for their own home: 
“I think, if I'm here, just sitting here, it feels comforting. I feel better at 
home.” (Participant 8) 
 “I don't know, I just... I feel my Huntington's. […] I just need to get in the 
house, get in my comfy house.” (Participant 6) 
However, as a couple of participants further elaborated, the idea reached 
a deeper level of meaning which transcended the geographical space and 
embraced a more abstract concept of safety. For example, Participant 4 talked of 
his ‘little world’: 
“I go back into my little world, you know what I mean […] I just shut down, 
I don't know how I'm doing it *laughs*” (Participant 4) 
 Similarly, Participant 5 mentioned her ‘little bubble’: 
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“I know that sounds so ignorant, but I can just sort of getting into my little 
bubble and just completely close down if I need to, you know.” 
(Participant 5) 
 This mental safety net appeared to have developed to help the 
participants deal with their everyday emotional and communicative life: when 
fatigue kicked in, emotions became overwhelming, or the circumstances got too 
demanding they could return to their shelter - of which their house in some cases 
only seemed to constitute a physical representation: 
“I just seem to be able to switch off because I don't know what we are 
talking about. […] It's quite hard to explain... I just shut up... I just shut 
down and ignore people and then I look back here [at home].” 
(Participant 4) 
From this perspective, the idea of sheltering appeared to provide the 
participants with an effective coping mechanism to boost their self-confidence. By 
knowing that they had a safe shelter, they could feel safer while dealing with 
everyday life’s demands. Indeed, as consequence of the process of taking shelter, 
of ‘feeling like in their own home’, they could also feel comfortable enough to open 
up again and communicate: 
“I do try to talk to people. Sometimes when I just feel... like in my own 
home. Yeah, my own home. So I invite people to come around here, to chat 
with people.” (Participant 6) 
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Therefore, along with the aforementioned beneficial effects of 
medications and close relationships, sheltering seemed to play an important role 
in maintaining or restoring participants’ communicative abilities 
Discussion 
Summary of main findings 
The four themes identified by our study showed substantial areas of 
relevance to current models and theories of communication and psychological 
adjustment to chronic illness. The first theme concerned how HD acts as both 
director and mediator of the participants’ communication, affecting their linguistic 
abilities by making them feel blocked and not able to speak as they used to, or 
pulling the strings of a number of collateral conditions that deeply affected their 
communicative experience, such as chronic fatigue and memory problems. 
According to the self-regulation model (SRM; 25), patients’ representations and 
beliefs regarding their chronic illness have a substantial effect on the successful 
development of coping strategies and ultimately their psychological well-being. 
The SRM has been specifically adopted with HD,26,27 finding that the perceptions 
of the disease are often characterised by strong illness identity due to its 
overwhelming perceived effect on all domains of their life. From this perspective, 
by conceiving HD as an external, separate agent the participants seemed to lay the 
foundations to fight for a fundamental domain of their own life by taking back 
some control over communication, which in turn can promote an identity less 
characterised by their illness.  
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The importance of control was emphasised in the second theme: retaking 
control over the features of communication appeared to represent an effective 
coping strategy aimed at improving the participants’ communicative skills. 
Whether it was the possibility to avoid phone conversations, the decision to 
prioritise listening over speaking, the management of scarce energy resources, or 
being open about HD, regaining aspects of control affected the participants 
positively by giving them a chance to break free from the pervasive nature of HD, 
better accept their condition and become the director of their communication once 
again. This view fits with the general theory of self-regulation,28 which sees self-
regulatory skills as a limited resource that can be exhausted – a phenomenon 
which has been named self-regulatory fatigue or ego depletion29 and that plays a 
pivotal role in quality of life and coping in chronic illness30,31. Thus, regulating 
energy and fatigue by having a choice can represent an effective strategy to deal 
with the demanding nature of communication.  
The third theme focused on how HD threatened participants’ emotional 
life and stability. Presentations of this included inconsistent feelings of anger and 
sadness, apathy, and considerably longer emotional ‘cool-down’ times, which are 
not uncommon in HD1. These ultimately led the participants to perceive their 
emotions and communication as a source of unsteadiness. One possible solution 
was represented by improving emotion regulation, which is a concept that refers 
to the process of influencing which emotions one experiences, as well as when and 
how such experiences occur,32 and whose importance in mental health and well-
being has been widely recognised over the last decade.33–35 However, for the 
participants emotion regulation required engaging with difficult and disturbing 
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thoughts, leading to challenging emotional outflows into their communicative 
attempts, which caused pervasive feelings of anxiety that could turn 
communication itself into “a double-edged sword”. Nonetheless, where a better 
level of separation between emotions and communication was achieved (and also 
thanks to the medication and supportive social relationships), emotion regulation 
allowed for a substantial improvement in their willingness to communicate.  
Last, the fourth theme explored a coping strategy adopted by many 
participants:  the idea of having a personal safe place where they could take 
shelter. This was initially identified with their home, but later exceeded the 
physical dimension and extended to a more abstract idea of safety, a “little bubble” 
where they could switch off. The idea of sheltering provided the participants with 
a feeling of safety that helped them deal with stressful situations, and eventually 
shaped an effective mechanism to boost their self-confidence in regulating 
emotions and regaining control over communication. This finding seems 
consistent with the positive effect of feelings of safety reported by Hartelius and 
colleagues.17  
While a number of the overall features of the communication impairments 
found in our study – such as general difficulties of emotional processing – are often 
observed in a variety of neurodegenerative conditions (e.g., Alzheimer’s disease 
and Parkinson’s disease37–40), some of the more detailed aspects are more likely to 
be specific to HD. In particular, in HD’s case the difficulty in reading or 
understanding situations during communication is likely to be a direct 
consequence of the inability to recognise emotions efficiently, which is known to 
be characteristically part of the cognitive manifestations of the disease.7 Moreover, 
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given the loss of control on body movements that is characteristic to HD’s 
symptomatology, it could be hypothesised that the particular emphasis on the 
theme of control, mentioned by the participants, might represent a way to cope 
with the threats posed by this condition in particular.  
Limitations and future directions 
A number of limitations should be considered with our results, such as the 
inclusion of people at the early to moderate stages only, In this study the SRM was 
adopted as a general theoretical framework to interpret the findings, since it has 
produced meaningful conclusions in previous  studies with people affected by 
HD.26,27 However, other theoretical models could also be useful – such as Sharpe 
and Curran’s hierarchical model on world and self views36 – and future studies 
could take advantage from their adoption. It should also be remembered that 
communication is only one aspect of a number of challenges which these 
participants were managing. Seeing this in the context of their more general illness 
experience is also important theoretically. Future research should also aim to find 
ways to investigate the personal experiences of people at later stages of disease, 
using more adapted communication methods such as LiteWriters™.  
Conclusion and implications for clinical practice 
Our study has helped shed new light on multiple factors that have the 
potential of informing clinical communicative strategies between clinicians, 
caregivers, and patients with HD. First, our results suggest that patients could be 
encouraged to develop an identity which is less focused on the belief that the 
biomedical manifestations of HD are responsible for all the difficulties that they 
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experience. Stigmatising language (e.g., ‘the Huntington’s face’) should be avoided. 
Secondly, patients should be allowed to regain actively some control over various 
features of communication, by, for example,  having a choice on avoiding phone 
conversions, or managing their own energy in a way which is not then 
pathologised.  
Finally, more effort should be put into helping patients reach a better level 
of emotion regulation. This could be achieved through the combination of a wide 
number of factors, including the review of medication regimes, the promotion of 
close relationships, the refinement of current coping strategies (such as 
sheltering), and their inclusion in new therapeutic interventions.   
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Tables 
Table 1  
Participants demographic data. 
Participant Gender Age (yrs) Diagnosis (yrs) HD Stage 
1 F 53 5 Moderate 
2 F 53 7 Early 
3 M 53 9 Moderate 
4 M 41 5 Moderate 
5 F 50 5 Early 
6 F 62 5 Early  
7 M 57 8 Early 
8 F 49 6 Moderate 
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Table 2 
Final list of identified themes and breakdown of relative codes. 
Theme Codes 
“You ever wanna say thing to people, but you can’t”: how HD directs and mediates 
communication 
Articulation is harder 
Chronic fatigue makes communication harder 
Fear of saying or doing something wrong 
Interrupting or jumping into a conversation 
Memory has changed 
Not into communication anymore 
 Not understanding what is going on 
Not willing to go out 
Public places are uncomfortable 
Speaking is harder 
The HD face 
Writing is harder  
Becoming a director again: regaining control to improve communication 
Being open about HD helps communication 
Communication with familiar people is easier 
Communication with more than one person is 
harder 
Communication with strangers is harder 
Getting used to new people helps 
communication 
Listening rather than speaking 
New or unexpected things are harder 
New technologies can be helpful 
Not using the phone anymore 
Texting helps communication  
Physical contact and proximity are 
harder 
Retiring from work is helpful 
“One moment I’m fine, the next moment I’m not”: emotional outflows into communication and 
the struggle for separation 
Acceptance helps with emotions 
Emotions have changed 
Feeling discriminated 
Feeling ignored 
Feeling lonely  
Feeling misunderstood 
Having a close family is helpful 
Having relatives or friends around is 
helpful 
Medications help with emotions 
“I go back into my little world”: sheltering as a way to boost confidence in communication 
Home is a safe place 
My little bubble 
My little world  
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Interest in the role of both emotion regulation and recognition in our 
understanding of mental health has been steadily increasing, especially in people 
with chronic illness who also have psychological difficulties. One illness which 
belongs to this category is Huntington’s disease. Huntington’s disease (HD) is a 
chronic neurodegenerative disorder that can cause a number of cognitive and 
psychological difficulties, including emotion recognition deficits, even before the 
onset of the symptoms required to make a formal diagnosis. Despite the lack of 
definite evidence, recent studies have suggested that deficits of emotion regulation 
and recognition may be expected to play a pivotal role in the early cognitive 
manifestations of HD.  
In this study, we hypothesised that the ability to regulate emotions can be 
impaired in people with presymptomatic HD, and that such impairment may be 
associated with a deficit of emotion recognition. To test this, an online survey was 
carried out with 117 English and Italian-speaking people with presymptomatic 
HD, compared to 217 controls matched for age and education. 
The results suggest that, in presymptomatic participants, emotion 
regulation and emotion recognition are generally not significantly impaired, and 
no significant relationships between performances on the two constructs were 
observed. However, a specific impairment in emotional awareness (a subscale on 
the Difficulties in Emotion Regulation Scale, DERS) was observed, which appears 
to be enhanced by the co-occurrence of depressive symptoms, even at a subclinical 
level. Consequently, it is suggested that difficulties in emotional awareness may 
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represent a precursor of more general emotion recognition impairments, which 
only become apparent as the disease reaches a more symptomatic level. Clinical 
implications of the findings are discussed and directions for future research are 
proposed. 
  





Emotion regulation is defined as the process of managing the emotions 
that one has, as well as when and how one experiences or expresses them (Gross, 
1998; Mayer, 2001). It involves both negative and positive emotions and its 
successful operation for good mental health has been widely recognised, with a 
substantial increase in the number of empirical investigations addressing this 
broad research area in the last two decades (e.g., Eftekhari, Zoellner, & Vigil, 2009; 
Gross, 2013; Gross & Muñoz, 1995). The most popular framework that has been 
developed to explain its functioning is the Process Model of Emotion Regulation 
(Gross, 1998), which identifies five fundamental families of regulatory emotional 
processes: a) Situation selection, i.e. taking necessary actions to approach or avoid 
situations potentially involving emotional responses; b) situation modification, i.e. 
modifying a situation in order to affect its emotional impact; c) attentional 
deployment, i.e. deploying or distracting attention in a situation to alter the 
emotional response; d) cognitive change, i.e. changing point of view or perspective 
on a situation in order to change the emotional response; e) response modulation, 
i.e. taking direct action on managing the behavioural and physical components of 
the emotional response. The latter two processes are responsible for the two main 
strategic outcomes of emotion regulation: reappraisal, which originates from 
cognitive change and involves actively rethinking a situation to alter the emotional 
response, and emotion suppression, which belongs to the response modulation 
family and promotes the decrease of emotion expression (Gross, 2013). While 
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reappraisal is a cognitively-oriented strategy that has proven to be particularly 
beneficial for the regulation of negative emotions and the promotion of positive 
experiences, the evidence on emotion suppression (which, by contrast, is a 
behaviourally-oriented) shows limited benefits and suggests the potential for 
mainly detrimental effects such as increased negative experiences, and memory 
difficulties (for a meta-analysis, see Webb et al., 2012).  
Regardless of their specific efficacy, however, the successful 
implementation of emotion regulation strategies is based on the accurate 
functioning of a number of fundamental physiological, behavioural, and cognitive 
mechanisms that are known to be involved in emotional processing and response 
(Mauss et al., 2005). These include the ability to recognise emotions in other 
people, which represents a key cognitive and social skill and whose impairment is 
likely to cause emotional dysregulations. This is especially true in clinical 
conditions where emotion recognition is frequently impaired, such as in 
neurodegenerative disorders (Löffler et al., 2015). 
Emotional difficulties in neurodegenerative disorders: the case of 
Huntington’s disease 
Huntington’s disease (HD) is a hereditary progressive neurodegenerative 
disorder which affects 5-10 people  per 100,000 in the Caucasian population 
(Roos, 2010). Typical symptoms include involuntary movements (chorea), 
involuntary abnormal postures (dystonia), cognitive deterioration (dementia) and 
significant psychological problems (Novak and Tabrizi, 2005). Since the 
transmission mechanism is autosomal-dominant, every affected individual has a 
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50% probability of transmitting it to their children. The estimate range of age of 
onset is 40-50 years, and the mean life expectancy after the diagnosis is typically 
20 years (Folstein, 1989). Genetic testing is available for individuals at risk, 
allowing them to know if they carry the mutated gene. Individuals with this gene 
mutation will develop the disease at a certain time in their life, and are defined as 
‘presymptomatic’. The full diagnosis of Huntington's disease is based on the 
development of motor symptoms along with a familiar history (i.e., proof of an 
affected parent). Cognitive and psychological changes, including emotional 
problems, do not have to be present for a diagnosis to be made, even though they 
can arise much earlier than motor impairment, thus still affecting 
‘presymptomatic’ individuals.  
An impairment in the ability to recognise emotions has been widely noted 
in empirical studies in people with symptomatic HD, with both cross-sectional and 
longitudinal investigations consistently reporting evidence of early deterioration 
in the facial recognition of negative emotions, more specifically anger, fear, and 
disgust (e.g., Bates et al., 2014; Dumas et al., 2013; Henley et al., 2012; Johnson et 
al., 2007; Robotham et al., 2011). Evidence in people with presymptomatic HD for 
the same set of deficits is more sparse and contrasting, with some within subjects 
studies reporting specific impairments for disgust and negative emotions and 
others reporting no significant impairment at all (for a systematic review, see 
Henley et al., 2012). On the other hand, very little is currently known about 
emotion regulation in people with neurodegenerative disorders, and HD in 
particular. For example, a recent review (Löffler et al., 2015) was able to retrieve 
only one study, which found no differences between people with symptomatic HD 
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and controls in the self-reported usage of emotion suppression and reappraisal 
(Croft et al., 2014). Moreover, no studies were retrieved on emotion regulation in 
people with presymptomatic HD, and to our knowledge none has ever been 
carried out.  
However, as previously anticipated, emotion recognition plays a pivotal 
role in the successful implementation of emotion regulation, and impairments in 
emotion recognition are likely to contribute to the development of emotion 
regulation difficulties, especially in clinical populations (Cecchetto et al., 2014; 
Gray and Tickle-Degnen, 2010; Löffler et al., 2015). In particular, according to 
emotional intelligence theory (Mayer, 2001; Salovey and Mayer, 1989), emotion 
regulation can only occur after emotions have been recognised (Izard et al., 2001; 
Yoo et al., 2006). With specific reference to the abovementioned Process Model, 
the inability to recognise emotions effectively seems likely to impair the 
regulatory processes that are based on the accurate emotional assessment of 
people and situations. Such processes could include situation selection (e.g., not 
being able to recognise those that are potentially negative), attentional 
deployment (e.g., not recognising relevant emotional cues), and cognitive change 
(e.g., basing change on misrecognised emotions). This is further corroborated by 
current evidence of a significant correlation between deficits of emotion 
recognition and emotion regulation difficulties in other clinical populations, such 
as people with anorexia nervosa (Harrison, Sullivan, Tchanturia, & Treasure, 
2009), bulimia (Harrison et al., 2010), and borderline personality disorder (Domes 
et al., 2009). Moreover,  recent evidence on anorexia nervosa has also shown 
associations between specific components of emotion regulation and 
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psychological difficulties such as depression and anxiety (Racine and Wildes, 
2013). Thus, in the particular case of HD, it would be expected that emotion 
regulation and emotion recognition could play a major role in the early cognitive 
and psychological difficulties that occur prior to the formal diagnosis. This in turn 
represents the main argument of a currently ongoing debate on whether more 
comprehensive diagnostic criteria should be considered for the disease (Loy and 
McCusker, 2013; Paulsen, 2011; Reilmann et al., 2014). 
Consequently, considering the evidence of potential early emotion 
recognition deficits in presymptomatic people (Henley et al., 2012) as well as the 
link between emotion recognition deficits and regulation impairments observed 
in other clinical populations (Harrison et al., 2010; Harrison et al., 2009; Racine 
and Wildes, 2013), the overarching aim of this study was to investigate the 
hypothesis that emotion regulation abilities can be impaired in presymptomatic 
HD gene carriers, and that such impairment may manifest in association with a 
deficit of emotion recognition. More specifically, the following hypotheses were 
formulated for this study: a) People with presymptomatic HD were predicted to 
report significantly more emotion regulation difficulties when compared to 
controls; b) performance on emotion recognition was predicted to be worse in 
people with presymptomatic HD when compared to controls; c) a significant 
positive relationship was predicted between difficulties in emotion recognition 
and emotion regulation, with more difficulties in emotional recognition 
correlating with more difficulties in emotional regulation. Moreover, in order to 
make sure to explore possible associations between emotion regulation and 
   
 
 139 
recognition with psychological difficulties, depression and anxiety were also 
measured.  
Materials and Methods 
Design 
This study adopted an online survey to explore emotion regulation and 
recognition in people with presymptomatic Huntington’s disease with age-
matched (non-affected) controls.  The survey was developed with the Qualtrics® 
software, and included measures for emotion regulation, emotion recognition, as 
well as anxiety and depression. Both English and Italian versions of the survey 
were developed. The Italian version was developed via an ongoing collaboration 
between the Division of Health Research (DHR) at Lancaster University and the 
Italian League for Research on Huntington and Related Disease (LIRH Foundation) 
at the Mendel Institute of Human Genetics in Rome. The aim was to expand the 
sample size and was possible due to the availability of standardised translations 
of all the included measures that report the same validity as the English version. 
Separate links were generated to facilitate the dissemination among the target 
populations. 
Participants 
In total, 334 participants took part in the present study. The power 
calculation showed that, assuming a small effect size (d = .2), a minimum sample 
of 188 participants (99 for each group) was required to achieve a minimum 
statistical power of .8 using a probability value of 0.05.. The first group (Pre-HD) 
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consisted of 117 people with presymptomatic HD, of which 83 were English-
speakers and 34 Italian-speakers. The second group (Ctrl) consisted of 217 age-
matched controls, of which were 69 English-speakers and 148 Italian-speakers. An 
initial self-report question was included for the Pre-HD versions of the survey in 
order to control the participants’ presymptomatic status. The presymptomatic 
participants and the controls did not present any significant differences in terms 
of age [t(305.767) = 1.789, p = ns], years in full-time education [t(189.749) = -
1.864, p = ns], and gender [X2(2, N = 334) = 1.606, p = ns]. See Table 1 for the full 
demographic details of the participants.  
Table 1 
Demographics of the participants. 
Note. Ctrl = control group; F = female; M = male; Min-Max = minimum-maximum value; N = count; 
Pre-HD = presymtomatic group; SD = standard deviation; yrs = years.  
 
The participants were enrolled across the UK and other English-speaking 
countries (e.g., USA, Canada, Australia and New Zealand), as well as Italy and San 
Marino via social media and with the help of local and international Huntington’s 
disease associations. All the participants reported to be native speakers of the 
respective languages.  
 
 Pre-HD Ctrl 
 N Mean (SD) Min-Max N Mean (SD) Min-Max 
Language (EN/IT) 83/34  69/148  
Gender (M/F) 35/82  59/158  
Age (yrs) 117 37.38 (11.06) 19-70 217 40 (15.39) 18-74 
Education (yrs) 117 14.49 (2.77) 11-21 217 13.94 (2.11) 11-17 
Test-time (yrs) 117 5.09 (5.34) 0-30   




Emotion recognition measures 
Reading the Mind in the Eyes test 
The Reading the Mind in the Eyes test (RME; Baron-Cohen et al., 2001) is 
a test consisting of 36 still pictures of the eye regions within faces expressing 
different emotional states. The participant is asked to match a list of provided 
emotional tags to the emotions displayed in the pictures. The test yields a total 
score out of 36, and higher scores equal higher recognition performance. The RME 
is used worldwide and has been adopted with many clinical conditions, including 
schizophrenia (Kettle et al., 2008), autism (Baron-Cohen et al., 2001) and anorexia 
nervosa (Harrison et al., 2009), as well as Huntington’s disease (Allain et al., 2011). 
It has previously shown acceptable construct validity when compared to other 
emotion recognition tasks (Alaerts et al., 2011), as well as acceptable internal 
consistency (Cronbach’s α = .63 for men, .60 for women; Voracek and Dressler, 
2006). The Italian translation by Vellante and colleagues (2013) was used for the 
Italian version of the survey, which has shown good construct (discriminant and 
convergent) validity and acceptable internal consistency (Cronbach’s α = .60). 
Emotion regulation measures 
Difficulties in Emotion Regulation Scale 
The Difficulties in Emotion Regulation Scale (DERS; Gratz & Roemer, 
2004) is a validated self-report questionnaire consisting of 36 items rating 
emotion regulation on a 5-point Likert scale. It includes 6 subscales: non-
acceptance of emotional responses (NONACCEPT), difficulties engaging in goal 
   
 
 142 
directed behaviour (GOALS), impulse control difficulties (IMPULSE), lack of 
emotional awareness (AWARE), limited access to emotion regulation strategies 
(STRATEGIES), lack of emotional clarity (CLARITY). It yields a subscore for each 
subscale, as well as total score (SUM) out of 180. As the focus of the test is on 
difficulties, higher scores equal poorer emotion regulation. To our knowledge, the 
DERS has never been adopted with HD; however, it has been used with several 
other clinical populations, including participants with both psychological (Fowler 
et al., 2014) and physical conditions (Kökönyei, Urbán, Reinhardt, Józan, & 
Demetrovics, 2014). The DERS has previously shown good construct validity 
(Kökönyei et al., 2014), even when adopted across different cultural and ethnical 
groups (Ritschel et al., 2015). It also showed very good internal consistency, with 
a Cronbach’s α of .93 for the total score (SUM), and figures ranging between .80 
and .89 for the subscales (Gratz and Roemer, 2004). The Italian validation by 
Sighinolfi and colleagues (2010) was adopted for the Italian version of the survey, 
which has showed psychometric properties comparable to the English version.  
Mood and anxiety issues measures 
Hospital Anxiety and Depression Scale 
The Hospital Anxiety and Depression Scale (HADS; Zigmond & Snaith, 
1983) is a validated self-report questionnaire consisting of 14 items rating anxiety 
and depression symptoms on a 3-point scale. No unified score is provided at the 
end of the test. Instead, individual scores on a scale out of 21 are provided for 
anxiety and depression. The HADS represents one of the most adopted measures 
in clinical populations and it has been specifically validated with people affected 
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by HD (De Souza et al., 2010). A review of its psychometric properties (Bjelland et 
al., 2002) reported good construct validity when compared to other common 
clinical measures, as well as good internal consistency (mean Cronbach’s α = .83 
for anxiety, .82 for depression). The same study identified a recommended cut-off 
point of 8/21 to yield both good sensitivity (anxiety = .90; depression = .83) and 
specificity (anxiety = .78; depression = .79). The HADS was incorporated in this 
study to control for the potential confounding effect of depression and anxiety 
levels on the ability to regulate and recognise emotions. For the Italian version of 
the survey, the validation by Costantini and colleagues was adopted (1999), which 
showed comparable high construct validity and internal consistency (Cronbach’s 
α = .89 and .88 for anxiety and depression respectively).   
Statistical analysis 
Data were analysed with IBM SPSS Statistics® programme v23 (Armonk, 
NY: IBM Corp). Independent-sample t-tests and one-way ANOVAs were performed 
to compare means across the participants groups. Considering the number of 
repeated comparisons, in order to control for family-wise error-rate (FWER) the 
Bonferroni correction was applied and the significance level was adjusted from .05 
to .005. The relationship between the participants’ demographic and clinical 
characteristics and the outcome variables (i.e., emotion regulation, emotion 
recognition, depression and anxiety) was investigated through Pearson’s 
correlations (two-tailed). 
  




This study was reviewed and approved by the Faculty of Health and 
Medicine Research Ethics Committee at Lancaster University (ref: FHM 
REC16015).  
Results  
Despite the differences in language and culture between English and 
Italian-speaking participants, a whole pool of presymptomatic individuals (Pre-
HD) and a whole pool of controls (Ctrl) were considered for the purpose of the 
analysis. This decision was taken on the basis of the widely confirmed observation 
in the literature that the expression of emotions is a universal ability which is not 
affected by language or culture (Ekman, 1993; Ekman & Cordaro, 2011; Ekman & 
Friesen, 1986; Fritz et al., 2009; Keltner, Ekman, Gonzaga, & Beer, 2003; Wells, 
Johnson, Ekman, Sorenson, & Friesen, 1969). Therefore, the implicit assumption 
of the present study was that English and Italian-speaking participants would not 
differ significantly regarding the constructs evaluated by the adopted measures.  
The mean scores of the participants of the Pre-HD and Ctrl groups on the 
outcome variables are shown in Table 2. Based on the recommended cut-off values 
of skewness and kurtosis (West et al., 1995), the scores were normally distributed. 
Of the participants of Pre-HD group, 48.7% and 23.1% showed clinical levels of 
anxiety and depression respectively, by scoring above the recommended clinical 
cut-off for the HADS (i.e., 8/21; Bjelland et al., 2002). The participants of the Ctrl 
group showed similar figures, with 46.5% and 23.5% above the cut-off point. In 
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terms of levels of emotion regulation difficulties, the Ctrl group showed total 
scores (SUM) comparable to the reported data with general adult populations (e.g., 
77/180; Ritschel et al., 2015), while the Pre-HD group scored marginally higher, 
meaning that more emotion regulation difficulties were reported. The mean 
emotion recognition performance of both groups was very similar and slightly 
below the reported normative data for general adult populations (e.g., 26/36; 
Baron-Cohen et al., 2001). In terms of measure reliability, high levels were shown 
by the HADS (Cronbach’s α = .84/.78 for anxiety/depression) and the DERS 
(Cronbach’s α = .94 for the SUM score, .83 to .89 for the subscales). The RME 
showed a level of reliability (Cronbach’s α = .55) comparable to previously 
accepted figures in the literature (Voracek and Dressler, 2006). 
The group comparison showed that the Pre-HD and Ctrl groups did not 
differ significantly in terms of total score of emotion regulation difficulties (DERS 
SUM; [F(1, 332) = 1.939, p = ns]), emotion recognition (RME; [F(1, 332) = 1.291, p 
= ns]), as well as anxiety (HADS-A; [F(1, 332) = 1.472, p = ns]) and depression 
(HADS-D; [F(1, 332) = .393, p = ns]). When comparing the subscales of the DERS, 
significant differences were observed only on the AWARE score [F(1, 332) = 9.359, 
p = .002].  Effect size analysis indicated no relevant effects of any of the other 
variables, except for a small effect of the IMPULSE score (d = .220). The full details 
of the results of the comparisons are shown in Table 2.  
In addition, no significant correlation was found between the total level of emotion 
regulation difficulties (DERS-SUM) and emotion recognition performance (RME) 
in the overall presymptomatic group (r = -.030, N = 117, p = ns). Similarly, no 
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significant correlation was observed between the same constructs when assessed 
separately for participants’ language, within either the presymptomatic (English: 
r = -.114, N = 83, p = ns; Italian r = -.077, N = 34, p = ns). Table 3, 4, and 5 show the 
full details of Pearson’s correlation coefficients across all the variables for the 
overall, English, and Italian Pre-HD participants’ scores respectively. 
Table 2 
Participants’ scores across the outcome variables.  
Note. Clinical cut-off for the HADS: 8/21. Significance level = .005; α = Cronbach’s alpha; AWARE = 
lack of emotional awareness; CLARITY = lack of emotional clarity; Ctrl = control group; DERS = 
Difficulties in Emotion Regulation Scale; F = ANOVA F value; GOALS = difficulties engaging in goal 
directed behaviour; HADS-A = HADS anxiety score; HADS-D = HADS depression score; IMPULSE = 
impulse control difficulties; NONACCEPT = non-acceptance of emotional responses; Pre-HD = 
presymptomatic group; RME = Reading the Mind in the Eyes test; SD = standard deviation; Sig. = 
significance; Size = effect size; SUM = DERS total score.  
 Pre-HD Ctrl Between-group comparison Reliability 
Mean (SD) Mean (SD) F p d α  
HADS 
HADS-A 7.85 (4.78) 7.24 (4.16) 1.472 ns .136 .84 
HADS-D 4.77 (3.911) 5.04 (3.61) .393 ns -.071 .78 







1.939 ns .155 .94 
NONACCEPT 12.98 (5.59) 13.26 (5.83) .174 ns -.049 .87 
GOALS 13.12 (5.30) 12.95 (5.05) .079  ns .032 .87 
IMPULSE 11.93 (5.33) 10.86 (4.35) .946 ns .220 .85 
AWARE 15.77 (5.91) 13.83 (5.31) 9.359 .002 .345 .83 
STRATEGIES 16.90 (7.54) 16.42 (6.79) .348 ns .066 .89 
CLARITY 10.21 (4.28) 9.65 (4.14) .1335 ns .132 .84 
        
RME 
Total Score 24.07 
(3.863) 
24.58 (3.97) 1.291 ns -.130 .55 




Correlation coefficients for pre-HD participants’ scores (overall; N = 117).  
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 
1. Gender               
2. Age -.157              
3. Education -.080 -.001             
4. Test -.036 .286** .057            
5. HADS-A .157 -.098 .030 -.130           
6. HADS-D -.002 -.006 -.093 -.146 .669**          
7. DERS SUM .104 -.065 .055 -.133 .758** .760**         
8. DERS NONACCEPT .141 -.006 .067 -.070 .572** .501** .796**        
9. DERS GOALS .147 -.040 .117 -.094 .667** .628** .826** .570**       
10. DERS IMPULSE .110 .019 .072 -.131 .618** .580** .803** .561** .619**      
11. DERS AWARE -.055 -.072 -.085 -.148 .400** .513** .662** .423** .384** .391**     
12. DERS STRATEGIES .115 -.074 .093 -.057 .764** .745** .925** .709** .786** .762** .434**    
13. DERS CLARITY .040 -.153 -.016 -.181 .643** .727** .841** .587** .655** .547** .606** .751**   
14. RME .153 -.026 .194* .012 -.058 -.184* -.030 .061 .058 -.058 -.155 -.018 -.030  
Note. * = p<.05; ** = p<.01; AWARE = lack of emotional awareness; CLARITY = lack of emotional clarity; DERS = Difficulties in Emotion Regulation Scale; GOALS = 
difficulties engaging in goal directed behaviour; HADS-A = HADS anxiety score; HADS-D = HADS depression score; IMPULSE = impulse control difficulties; NONACCEPT 
= non-acceptance of emotional responses; RME = Reading the Mind in the Eyes test; SUM = DERS total score; Test = time since predictive test.  
  





Correlation coefficients for pre-HD participants’ scores (English; N = 83).  
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 
1. Gender               
2. Age -.118              
3. Education -.096 -.081             
4. Test -.074 .251** .107            
5. HADS-A .222* -.137 -.102 -.211           
6. HADS-D -.075 -.033 -.262* -.196 .634**          
7. DERS SUM .152 -.135 -.087 -.180 .725** .789**         
8. DERS NONACCEPT .178 -.074 .039 -.051 .612** .577** .821**        
9. DERS GOALS .244* -.087 .029 -.178 .567** .579** .799** .579**       
10. DERS IMPULSE .134 .043 .038 -.205 .589** .614** .785** .582** .589**      
11. DERS AWARE -.093 -.086 -.220* -.194 .349** .540** .652** .451** .302** .356**     
12. DERS STRATEGIES .194 -.164 -.011 -.079 .750** .764** .924** .732** .770** .735** .429**    
13. DERS CLARITY .067 -.139 -.166 -.205 .604** .724** .837** .592** .622** .522** .621** .738**   
14. RME .091 -.198 .241* .084 -.111 -.227* -.114 .008 .015 -.116 -.261* -.068 -.112  
Note. * = p<.05; ** = p<.01; AWARE = lack of emotional awareness; CLARITY = lack of emotional clarity; DERS = Difficulties in Emotion Regulation Scale; GOALS = 
difficulties engaging in goal directed behaviour; HADS-A = HADS anxiety score; HADS-D = HADS depression score; IMPULSE = impulse control difficulties; NONACCEPT 
= non-acceptance of emotional responses; RME = Reading the Mind in the Eyes test; SUM = DERS total score; Test = time since predictive test. 




Correlation coefficients for pre-HD participants’ scores (Italian; N = 34).  
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 
1. Gender               
2. Age -.242              
3. Education -.091 .175             
4. Test .051 .394* .111            
5. HADS-A .061 -.022 -.148 -.063           
6. HADS-D -.323 -.083 -.256 -.002 .695**          
7. DERS SUM .109 -.136 .225 -.069 .718** .507**         
8. DERS NONACCEPT .009 -.182 .202 -.199 .250 .981** .631**        
9. DERS GOALS .222 -.093 .106 -.139 .846** .697** .790** .327**       
10. DERS IMPULSE .015 .171 .200 -.046 .598** .352** .851** .394* .635**      
11. DERS AWARE -.037 -.053 -.074* -.055 .282 .176 .507** .104 .340* .336     
12. DERS STRATEGIES -.178 .193 -.192 -.053 .673** .532** .877** .502** .694** .814** .148    
13. DERS CLARITY -.104 -.053 -.215 -.181 .617** .633** .779** .420* .600** .508** .366** .682**   
14. RME .299 -.298 -.064 -.310 -.226 -.312 -.077 -112 -.195 -.074 -.046 -.154 -.020  
Note. * = p<.05; ** = p<.01; AWARE = lack of emotional awareness; CLARITY = lack of emotional clarity; DERS = Difficulties in Emotion Regulation Scale; GOALS = 
difficulties engaging in goal directed behaviour; HADS-A = HADS anxiety score; HADS-D = HADS depression score; IMPULSE = impulse control difficulties; NONACCEPT 
= non-acceptance of emotional responses; RME = Reading the Mind in the Eyes test; SUM = DERS total score; Test = time since predictive test. 
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Table 6  
Standardised coefficients for the multiple regression models of the AWARE subscore. 
Note. AWARE = lack of emotional awareness; β = standardised coefficient; Ctrl = control group; 
HADS-A = HADS anxiety score; HADS-D = HADS depression score; p = significance; Pre-HD = 
presymptomatic group. 
Despite not being initially hypothesised but in order to explore this result 
further, multiple regressions were conducted to assess the contribution of anxiety 
and depression to the AWARE subscale, as it was the only one to show a significant 
difference across the groups. The standardised regression coefficients are 
summarised in Table 6. Using the enter method, it was found that the model 
(which consisted of two variables) explained a significant amount of the variance 
of the AWARE score in both the Pre-HD (F(2, 114) = 20.947, p < .001, R2 = .269, 
R2Adjusted = .256) and Ctrl group (F(2, 214) = 5.623, p = .004, R2 = .050, R2Adjusted = 
.041). The analysis in the Pre-HD group showed that the AWARE score was not 
significantly predicted by anxiety (β = .128, p = ns), but it was significantly 
predicted by depression (β = .669, p < .001). On the other hand, in the Ctrl group 
neither anxiety (β = .129, p = ns) nor depression (β = .221, p = .ns) significantly 
predicted the AWARE score.  
Discussion 
To our knowledge, the present study has been the first to investigate 
emotion regulation abilities in a population of participants with presymptomatic 
Huntington’s disease (HD) by comparing these with those of age-matched 
 Pre-HD Ctrl  
 β p β p  
HADS-A .128 ns .129 ns  
HADS-D .669 .000 .221 ns  
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controls. In addition, it has also been the first to explore the relationship between 
emotion regulation and emotion recognition, as well the potential association with 
depression and anxiety, in this type of population. The results showed no 
significant differences between the two groups in terms of general difficulties in 
regulating emotions and performance on an emotion recognition task. Moreover, 
no significant correlation was found between emotion regulation and emotion 
recognition scores in both groups. As a consequence, none of our initial 
hypotheses was confirmed by the results, suggesting that the ability both to 
regulate and recognise emotions does not deteriorate early in non-symptomatic 
carriers of the gene Huntington’s disease, and these two abilities are not 
significantly correlated. This latter result appears to be in contradiction with 
previous findings in other clinical populations. However, it may be explained by 
the specific measure of emotion regulation used in this study as the DERS focuses 
specifically on difficulties rather than other components such as the use regulatory 
strategies. Thus, the lack of correlation in this study may be at least partially due 
to the specific adoption of the DERS, and the way it relates with the RME.  
When analysing more specific components of emotion regulation, a 
significant difference was found between the two groups on one subscale, with the 
presymptomatic participants reporting significantly greater lack of emotional 
awareness (DERS-AWARE), i.e. difficulties in the ability to attend to and 
acknowledge emotions. A possible explanation of this could lie in the development 
of some of HD’s early cognitive symptoms. Indeed, general difficulties of 
awareness and emotional processing have been linked to poorer functioning of 
prefrontal brain regions such as the anterior insular (AIC) and anterior cingulate 
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(ACC) cortices (Craig, 2009; Lane et al., 1998; Phillips, Drevets, Rauch, & Lane, 
2003), which are known to be affected by HD (Dogan et al., 2014; Gray et al., 2013) 
and are often responsible for a wide range of emotional difficulties in both 
symptomatic (Craufurd et al., 2001; Ho et al., 2006; Hoth et al., 2007; Mörkl et al., 
2016) and presymptomatic patients (Kipps et al., 2007; Klöppel et al., 2010). 
Therefore, the difference observed for the presymptomatic participants on the 
AWARENESS subscale of the DERS may represent an expression of the many 
subtle biological and cognitive changes that presymptomatic individuals can 
experience before a formal diagnosis of HD is made based on motor manifestations 
(e.g., Tabrizi et al., 2011).  
In particular, it could be interpreted in light of the early development of 
the well-established impairments in emotion recognition in people with 
symptomatic HD. This appears to be supported by multiple evidence of a 
significant predictive role played by alexithymia (a condition characterised by 
pervasive deficits of emotional awareness; Lane et al., 2000) in emotion 
recognition impairments both when it manifests alone (Lane et al., 2000, 1996), as 
well as when it is part of other clinical conditions, such as autism (Cook et al., 2013) 
and eating disorders (Brewer et al., 2015). Moreover, alexithymia measures often 
show high correlation levels with many of the DERS subscales, including the 
AWARE one (Ghorbani et al., 2017; Stasiewicz et al., 2012). In contrast, current 
evidence on alexithymia in HD is extremely limited, as a recent systematic review 
identified only one study that reported no significant impairment in symptomatic 
individuals (Ricciardi et al., 2015). Therefore, the significantly greater level of 
difficulties observed with the presymptomatic participants might represent a 
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precursory gateway to the development of the emotion recognition impairment 
found in fully symptomatic individuals, which in turn is likely to affect the other 
components of emotion regulation. This hypothesis requires further exploration, 
as it is currently uncertain whether emotional awareness difficulties may lead to 
a fully alexithymic condition in people with symptomatic HD. In addition, in this 
study the particular structure and sensitivity of the RME might have prevented the 
observation of any significant correlations between the specific AWARE subscale 
and emotion recognition performance (see Limitations section).  
Moreover, a considerable contribution to poorer emotional awareness 
may come from social and environmental factors, and more specifically from the 
type of family context, as many gene carriers often grow up in contact with a 
parent affected by symptomatic HD. Indeed, current evidence suggests that the 
family environment and the emotional climate in which a child is raised are deeply 
related to the successful development of emotional processing skills, and 
especially emotion regulation (for a review, see Morris et al., 2007). In particular, 
parents’ emotional responses to their children’s emotions have been linked with 
emotional awareness (Eisenberg et al., 1998; Schultz et al., 2001; Sim et al., 2009). 
Thus, the fact of living in a family context characterised by challenging emotional 
responses due to close contact with a symptomatic parent may have hampered the 
successful learning of the ability to acknowledge emotions in the presymptomatic 
participants of this study, ultimately contributing to the development of a deficit 
of emotional awareness in particular. 
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Further insight was also provided by the results of the regression models, 
which showed that depression explained a considerable portion of variance on the 
AWARE subscale in the Pre-HD group only. This differential effect of depression 
on presymptomatic participants could again represent an expression of the early 
cognitive manifestations of the disease. In particular, this may limit patients’ 
coping abilities and overall resilience in the face of depression, even when they 
have not reached clinical levels yet, in a way that is common to many 
neurodegenerative conditions (for a review, see Baquero, 2015). The predictive 
role of depression is also corroborated by findings from studies with clinically 
depressed individuals; these often show problems with many components of 
emotion regulation (Ehring et al., 2008; Loas et al., 1997), and in particular 
emotional awareness (Boden and Thompson, 2015). Thus, due to the concurrent 
development of psychological difficulties within the context of suboptimal 
psychological resilience due to HD’s early cognitive symptoms, depression might 
show a disproportionate effect on presymptomatic people even at subclinical 
levels. This may contribute to a greater lack of emotional awareness, and 
eventually lead to the development of emotion recognition impairments which, as 
previously mentioned, may in turn affect the other components of emotion 
regulation, thus establishing a symptomatic vicious circle. Figure 1 shows a 
schematisation of the hypothesised relationship.  




Figure 4: hypothesised relationship among the discussed constructs. Arrowed lines 
identify direct influence.  Upper case identifies main constructs, lower case 
subcomponents. Dotted lines identify inclusion within the same construct.  
Limitations and future directions 
Despite allowing for a large sample, the online nature of this study carries 
the intrinsic limitation of lacking direct contact between the researcher and the 
participants. This includes the inability to obtain some important clinical details 
about the participants (e.g., pharmacological therapies). In addition, the responses 
to all questions were made mandatory to proceed throughout the survey. While 
this eliminated the need to control for missing data, it might have also limited the 
sample size due to participants dropping out before completing their 
participation. To control for this issue, the number of measures was limited to 
keep the overall time of the survey below 30 minutes. In this perspective, the RME 
was chosen in this study as its brevity fit particularly well with an online design. 
However, despite being widely regarded and utilised as an emotion recognition 
test (Guastella et al., 2010; Harrison et al., 2010; Harrison et al., 2009; Quintana et 
al., 2012; Vellante et al., 2013), the measure was originally created as a test of 
theory of mind to assess the recognition of mental states through eye expressions 
(Baron-Cohen et al., 1997). As a consequence, it may be possible that the RME was 
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not sensitive enough to detect subtle differences in emotion recognition in the 
specific population of this study, nor may it be able to show potential correlations 
with emotional awareness.  
Future research should aim at adopting more diversified measures of 
emotion regulation and recognition in face to face studies. In particular, the 
adoption of emotion recognition tasks with more comprehensive stimuli based on 
both faces and body language – such as the recent Bochum Emotional Stimulus Set 
(BESST; Thoma, Soria Bauser, & Suchan, 2013) – may yield different results in 
terms of comparison of recognition performance and correlation between 
emotion recognition and emotional regulation. Moreover, more in-depth 
measures for emotional awareness and alexithymia should be used to investigate 
further the precursory role of emotional awareness difficulties hypothesised in 
this study, and further exploration is warranted on emotion regulation in people 
affected by HD with the adoption of measures focused on both difficulties and 
regulatory strategies.  
All these suggestions could generally benefit from the inclusion in large-
scale longitudinal clinical trials, which would allow an increase in our 
understanding of emotional processing in Huntington’s disease over its full clinical 
course.   
Conclusion  
This online study offered some preliminary insight into emotion 
regulation in people with presymptomatic Huntington’s, as well as further insight 
into emotion recognition. The findings suggest that presymptomatic individuals 
show a wide range of normal abilities, as emotion regulation and emotion 
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recognition were not significantly impaired when compared to controls, nor did 
the shared significant relationships with one another. However, one specific 
emotion regulation component, emotional awareness, was significantly impaired. 
This could be due to HD’s early cognitive manifestations, and a catalytic role may 
be played by their co-occurrence with psychological difficulties such as 
depression, even at a subclinical level. Moreover, the greater level of difficulties in 
emotional awareness shown by presymptomatic people may represent a 
precursor of the development of the emotion recognition impairments that are 
often observed in fully symptomatic individuals and that may in turn have a 
detrimental effect on the other components of emotion regulation.  
These findings can have important implications for clinical practice, as a 
better management of depression could lead to increased levels of emotional 
awareness, better emotion recognition performance, eventually better emotion 
regulation, as well as everyday communication and quality of life. In addition, the 
possible precursor role of emotional awareness shows the potential to help amend 
the current diagnostic criteria by shedding new light on early cognitive difficulties 
in HD, as well as inform new therapeutic protocols and interventions tailored 
around the emotional and communicative needs of the people affected by this 
condition. 
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Emotion regulation and emotional body language (EBL) recognition 
represent two fundamental components of emotional processing that have 
recently seen a considerable surge in research interest, especially due to the role 
they play in optimal mental health.  This appears to be particularly true for clinical 
conditions that can profoundly affect emotional functioning. Among these 
conditions is Huntington’s disease (HD), a neurodegenerative disorder that is 
associated with several psychological difficulties and cognitive impairments, 
which include well-established deficits in facial emotion recognition. On the other 
hand, the current evidence in this population on other components such as 
emotion regulation and EBL recognition is still sparse, and it is unsure whether 
they are also affected by the condition.  
In this study, it was hypothesised that emotion regulation and recognition 
of emotional body language are impaired in people with symptomatic HD, and that 
these impairments share a significant relationship with one another. Thus, a 
between-subjects design was adopted to compare 13 people with symptomatic HD 
with 12 non-affected controls matched for age and education. 
The results corroborated the first hypothesis, that emotion regulation and 
EBL recognition were significantly impaired by HD. Moreover, a significant 
positive correlation was observed between facial and EBL recognition 
impairments, and the EBL performance was negatively related to the stage of the 
disease. However, emotion regulation and recognition performances did not share 
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a general relationship with one another. Clinical implications of the findings are 
provided, and indications for future research are proposed. 
Introduction  
In the past few decades psychological research into human emotions has 
seen a surge of interest, especially due to the comprehensive conceptualisation of 
constructs such as emotional intelligence. Emotional intelligence is  defined as the 
set of cognitive processes that allows the accurate expression and appraisal of 
emotions in others and the self (Goleman, 1995; Salovey & Mayer, 1989). In 
particular, the identification, understanding, facilitation, and management of 
emotions have been recognised as the four fundamental areas required for the 
successful processing of emotions. Within this framework, a pivotal role in social 
and affective functioning is played by emotion recognition and emotion regulation 
(Ochsner, 2009).  
Emotion recognition can be defined as the process of correctly perceiving 
and identifying emotions in other people, as well as in artificial representations 
such as drawings or music  (Mayer, Caruso, & Salovey, 1999). Historically, the most 
researched medium of emotion recognition is whole facial expression, such as 
pictures of faces of actors expressing basic emotions such as anger or fear (Henley 
et al., 2012). However, emotion recognition is a process mediated by a number of 
different features other than facial clues, and recognition via eyes, voices, and body 
language have also been investigated (Baron-Cohen, Wheelwright, Hill, Raste, & 
Plumb, 2001; Beatrice de Gelder & Van den Stock, 2011; Lima, Castro, & Scott, 
2013). The latter medium in particular is gaining increased attention, since 
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emotional body language (EBL) recognition has so far been neglected, despite 
being deeply involved in fundamental social cognitive skills such as empathy and 
decision-making (de Gelder, 2006; de Gelder & Hortensius, 2014). 
On the other hand, emotion regulation is defined as the “processes by 
which individuals influence which emotions they have, when they have them, and 
how they experience and express these emotions” (Gross, 1998; p. 275). More 
specifically, it involves the processes of selecting and modifying potential 
emotional situations, deploying attention, changing one’s perspectives on 
emotions, and modulating emotional responses (Gross, 1998; 2015). In the last 20 
years this area  has seen a considerable increase in interest due to the recognition 
of its importance for psychological resilience and mental health (Aldao, Nolen-
Hoeksema, & Schweizer, 2010; Ghorbani, Khosravani, Sharifi Bastan, & Jamaati 
Ardakani, 2017; Gross & Muñoz, 1995; van der Meer, van Duijn, Giltay, & Tibben, 
2015).  
Based on the theory of emotional intelligence, emotion recognition and 
emotion regulation are deeply interconnected processes, since emotions need to 
be correctly recognised before being regulated (Izard et al., 2001; Mayer, 2001; 
Salovey & Mayer, 1989; Yoo, Matsumoto, & LeRoux, 2006). This is supported by 
evidence on the neural bases of both processes, which involve similar subcortical 
structures such as the limbic system and the basal ganglia (Gross, 2013). Not 
surprisingly, deficits of emotional processing are observed in many 
neurodegenerative conditions that involve a damage to those structures, such as 
Parkinson’s disease, Alzheimer’s disease, multiple sclerosis, and – with a 
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particularly well-established impact on emotion recognition skills – Huntington’s 
disease (Löffler, Radke, Morawetz, & Derntl, 2015).  
Huntington’s disease (HD) is a genetic neurodegenerative disorder whose 
typical symptoms include involuntary movements (chorea), cognitive 
deterioration (dementia), and considerable psychological problems (Novak & 
Tabrizi, 2005). Its prevalence in the Caucasian population is 5-10 people  per 
100,000 (Roos, 2010). The transmission mechanism is autosomal-dominant, 
meaning that affected individuals’ children have a 50% probability of inheriting 
the gene, and genetic testing is available to ascertain gene status (in which case 
the term ‘presymptomatic’ is used). The onset is usually around age 40, and 
disease progression can be divided into five stages, starting with mild motor 
symptoms, cognitive impairment and relative independent functioning (Stage I), 
and ending with a need for full-time care due to severe motor impairment and 
dementia (Stage V; Shoulson & Fahn, 1979).  
One of HD’s most frequently observed cognitive impairments is a deficit 
of emotion recognition, which especially involves negative emotions such as anger, 
fear, and disgust (Bates, Tabrizi, & Jones, 2014). However, while the evidence on 
this set of impairments is well established, it has been traditionally investigated 
only through tests based on facial expressions, with very few studies based on 
different stimuli such as emotional body language (see Henley et al., 2012 for a 
review). In fact, to our knowledge only two studies have investigated EBL in HD, 
showing preliminary evidence that a deficit of EBL recognition can also be part of 
the manifestations of the disease (de Gelder et al., 2008), although it may not be 
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observed in presymptomatic individuals (Aviezer et al., 2009). In addition to the 
sparseness of evidence on EBL, very little is also known about emotion regulation 
in HD. Indeed, a recent review (Löffler et al., 2015) identified only one study that 
specifically addressed it,  and that found no differences between people with 
symptomatic HD and controls (Croft, McKernan, Gray, Churchyard, & Georgiou-
Karistianis, 2014). However, the measure adopted by this study – the Emotion 
Regulation Questionnaire (ERQ; Gross et al., 2003) – only assesses the use of two 
regulatory strategies (suppression and reappraisal), and does not allow for the 
exploration of any other specific components of emotion regulation, such as 
impulse control or emotional awareness.  
As mentioned previously, emotion recognition (both facial and EBL) and 
emotion regulation are likely to influence each other (Ochsner, 2009), and play an 
essential role in the successful operation of social skills as well as psychological 
resilience (de Gelder & Hortensius, 2014; Ghorbani et al., 2017; Gross & Muñoz, 
1995). With specific regard to HD, a deeper understanding of how the disease 
affects these cognitive components would allow for a refinement of current 
cognitive and behavioural approaches to care and treatment. Moreover, this 
carries the potential for shedding new light on the neural bases that characterise 
them and the relationship between cognition and neurobiology, in particular in 
relation to EBL recognition (de Gelder, 2006). Both these implications have in turn 
the potential of contributing to a currently ongoing debate which focuses on 
whether the current diagnostic criteria for HD, which are based on motor 
manifestations only, should include early signs of cognitive impairment. (Loy & 
McCusker, 2013; Paulsen, 2011; Reilmann, Leavitt, & Ross, 2014) 
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Consequently, the aim of this study was to investigate the assumption that 
emotion regulation and both facial and EBL recognition are impaired in a 
population of people affected by symptomatic Huntington’s disease, and that such 
impairments may show a significant relationship with one another. In particular, 
the assumption was based on a comparison to non-affected age-matched controls 
with the use of more comprehensive tests of emotion recognition and regulation. 
More specifically, the following hypotheses were formulated: a) People with HD 
were predicted to report significantly more emotion regulation difficulties than 
the control group when assessed on a number of different emotion regulation 
components; b) emotion recognition was predicted to be significantly impaired in 
people with HD when compared to the controls on both facial and EBL tasks; c) a 
significant relationship was expected to be observed between emotion regulation 
difficulties and emotion recognition impairment. In addition, due to the evidence 
of relationships between psychological difficulties and emotional processing 
(Cisler, Olatunji, Feldner, & Forsyth, 2010; Joorman & Gotlib, 2010; Martin & 
Dahlen, 2005), depression and anxiety measures were also included.  
Materials and Methods 
Design and participants 
This study adopted a 2-group between-subjects design with age-matched 
controls. In total, 25 participants took part, split across two groups (HD and Ctrl) 
consisting of 13 symptomatic individuals (four male, nine female) and 12 age-
matched non-affected controls (five male, seven female). The sample size of the 
HD group was comparable to the majority of studies investigating emotion 
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recognition in HD that have been identified by a recent systematic review (i.e., six 
to 40; Henley et al., 2012). For the HD group, participation was limited to 
individuals in early to moderate stages of the disease (i.e., I-III). This was decided 
due to the difficulties in undertaking cognitive tasks that are likely to arise in the 
later stages of the condition. HD stage was screened through the Total Functional 
Capacity scale (TFC; Shoulson & Fahn, 1979). More specifically, one participant 
(7.7%) belonged to stage I, seven (53.8%) to stage II, and five (38.5%) to stage III. 
The two groups did not present any significant differences in terms of age [t(23) = 
.490, p = ns], education [t(23) = -1.023, p = ns], or gender [X2(1, N = 25) = .322, p = 
ns]. See Table 1 for the full demographic details. The participants of the HD group 
were recruited across the North West of England with the help of the Regional Care 
Advisory Service of the Huntington’s Disease Association (HDA). The participants 
of the Ctrl group were recruited from partners and caregivers of the participants 
of the HD group, in order to reflect similar demographic and social characteristics. 
This study was reviewed and approved by the Faculty of Health and Medicine 
Research Ethics Committee at Lancaster University (ref: FHMREC15043).  
Table 1 
Demographics of the participants. 
 HD    Ctrl   
 
 Mean SD Range  Mean  SD Range 
Age (yrs) 53.46  5.109 42-63  52.17  7.907 33-63 
Education (yrs) 12.92  2.66 11-18  14 2.594 11-18 
Diagnosis time (yrs) 5.54  1.713 3-9    
TFC score  6.92 2.139 13-0     
Note. Ctrl = control group; HD = Huntington’s disease group; SD = standard deviation; TFC = Total 
Functional Capacity; yrs = years. 




Total Functional Capacity Scale (Shoulson & Fahn, 1979): 
The TFC is a standardised tool that assesses everyday functional 
capacities such as working, handling money, taking care of domestic chores, 
performing self-care tasks, and living independently. It is part of the larger Unified 
Huntington’s Disease Rating Scale (UHDRS; Huntington Study Group, 1996). The 
total score ranges from 13 (normal capacity) to 0 (severe disability) and its 
intervals can be used to determine the stage of the disease: 13-11 = Stage I, 10-7 = 
Stage II, 6-3 = Stage III, 2-1 = Stage IV, 0 = Stage V. The TFC is characterised by 
excellent internal consistency (Cronbach’s α = .95) as well as high interrater 
reliability (Huntington Study Group, 1996). 
Bochum Emotional Stimulus Set (BESST; Thoma, Soria Bauser, 
& Suchan, 2013):  
The BESST is a validated set of 4490 emotional stimuli consisting of 
pictures of both male and female facial expressions and emotional body language 
(EBL). It investigates the recognition of six emotions (fear, disgust, happiness, 
sadness, surprise and anger) plus neutral expressions. The facial expressions are 
computer-generated, while the EBL stimuli are based on photographs of actors 
and actresses. The stimuli feature multiple ethnic groups, and the option to include 
averted pictures to allow for increased complexity. For this study, 10 frontal 
stimuli from the BESST were randomly selected for each emotion and each 
expression modality (facial or EBL), half male and half female, to a total of 140 
stimuli for two trials (70 + 70). Thus, the test in this study yielded a total score out 
of 70 for each modality, as well as a subscore out of 10 for each emotion. The BESST 
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features excellent norms (Abramson, Marom, Petranker, & Aviezer, 2017), with 
overall high recognition rates for the whole corpus (83.3/80.3% for 
frontal/averted faces, 85.5/87% for frontal/averted bodies; Thoma et al., 2013). 
Other measures of EBL recognition are available in the literature, such as the  
Bodily Expressive Action Stimulus Test (BEAST; de Gelder & Van den Stock, 2011). 
However, the latter only consists of the body language component and does not 
include stimuli for disgust. Therefore, as the recognition of all negative emotions 
plays a particularly important role in HD (Bates, Tabrizi, & Jones, 2014),  the BESST 
was preferred in this study due to its inclusion of disgust, as well as for being 
currently the only test to include both facial and EBL stimuli within a single set.  
Difficulties in Emotion Regulation Scale (DERS; Gratz & Roemer, 
2004) 
The DERS is a self-report questionnaire based on 36 items rated on a 5-
point Likert scale. It explores emotion regulation on the basis of 6 subscales: non-
acceptance of emotional responses, difficulties engaging in goal directed 
behaviour, impulse control difficulties, lack of emotional awareness, limited access 
to emotion regulation strategies, lack of emotional clarity. A subscore is yielded 
for each subscale, which can then be summed to create a total score out of 180 for 
the whole questionnaire. Higher scores correspond to more difficulties in emotion 
regulation. To our knowledge, the DERS has never been adopted with people 
affected by symptomatic HD, but it has been utilised with a number other clinical 
conditions (Fowler et al., 2014; Kökönyei, Urbán, Reinhardt, Józan, & Demetrovics, 
2014), showing very good construct validity (Ritschel, Tone, Schoemann, & Lim, 
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2015) and internal consistency (Cronbach’s α = .93/.89 for total score/subscales 
Gratz & Roemer, 2004).  
Hospital Anxiety and Depression Scale (HADS; Zigmond & 
Snaith, 1983) 
The HADS is one of the currently most adopted measures of mood and 
anxiety symptoms in clinical populations and consists of a self-report 
questionnaire based on 14 items rated on a 3-point scale. The outcome consists of 
individual scores out of 21 for both anxiety and depression. The HADS has been 
previously validated with people affected by HD (De Souza, Jones, & Rickards, 
2010), and features good construct validity and internal consistency, with a 
Cronbach’s α = .83/.82 for anxiety/depression respectively (Bjelland, Dahl, Haug, 
& Neckelmann, 2002). The suggested cut-off point for clinical depression and 
anxiety is 8/21, which guarantees good sensitivity (anxiety/depression = .90/.83) 
and specificity (anxiety/depression = .78/.79).  
Procedure  
In general, all the questionnaires were filled in by hand by the participants 
directly. However, in case of difficulties due to motor impairments, the questions 
were read out to the participants and their responses were recorded by the 
experimenter on their behalf. The two trials of the BESST were administered by 
the experimenter on a 15-inch laptop. Each stimulus was presented singularly on 
a black background in an 834x834 pixel format along with seven emotional labels 
on the right corresponding to the emotions investigated by the test. The 
participants were asked to name the label corresponding to the presented 
stimulus. This kind of multiple-alternative forced choice task has been adopted 
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before with the BESST (Abramson et al., 2017; Soria Bauser, Thoma, & Suchan, 
2012) and it currently one of the most widely utilised paradigms in the assessment 
of emotion recognition (Baron-Cohen et al., 2001; Calder et al., 1996; Beatrice de 
Gelder & Van den Stock, 2011; Ekman, P., Friesen, 1976; Sahakian & Owen, 1992). 
No direct interaction was required between the participants and the laptop. A 
practice session consisting of seven stimuli (one for each emotion) was 
administered prior to the beginning of each trial, to allow for familiarisation with 
the task. The order was kept constant among the participants, with the face trial 
being administered prior to the body language trial. No time limit was set for 
responses. However, the participants were asked to perform the tasks as quickly 
as possible. Figure 1 illustrates examples of neutral, positive, and negative stimuli 
administered via the BESST.  
Statistical analysis 
All the statistical analyses were performed with IBM SPSS Statistics® 
programme v23 (Armonk, NY: IBM Corp). On account of the relatively small 
sample size, non-parametric statistics were adopted. This is a common choice 
when working with small sample of symptomatic HD participants, and especially 
when investigating emotional processing (e.g., Croft et al., 2014; Snowden et al., 
2008; Trinkler, de Langavant, & Bachoud-Levi, 2013). Mann-Whitney tests were 
performed to make comparisons between the two participant groups, while two-
tailed Spearman’s correlations were utilised to investigate the relationship 
between the two main outcome variables. Effects sizes were calculated with 
Cohen’s d. In order to avoid loss of power due to the adoption of conservative 
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corrections with a small sample size, significance levels were conventionally set at 
p = .05 with no correction for multiple comparisons. This was in line with several 
previous studies on emotion recognition in small samples of people with HD (Croft 
et al., 2014; Ille, Holl, et al., 2011; Ille, Schäfer, et al., 2011; Novak et al., 2012; 
Robotham et al., 2011; Snowden et al., 2008; Sprengelmeyer, Schroeder, Young, & 
Epplen, 2006; van Asselen et al., 2012), as well as in other rare clinical populations 












Figure 1: Example of neutral, positive, and negative emotion stimuli administered via the 
BESST. On the top are stimuli for the face trial, on the bottom are stimuli for the body one. 
The left column shows neutral stimuli; the central column shows stimuli for happiness; 




Figure 2: Participants’ results on the emotion recognition tasks. Mean (and standard 
deviation) of correct responses for each of the six emotion category on the BESST, across 





















































































Participants’ scores across the outcome variables.  
Note. BESST TOTAL max score: 70. BESST single emotion max score: 10. Clinical cut-off for the HADS: 8/21. AWARE = lack 
of emotional awareness; CLARITY = lack of emotional clarity; Ctrl = control group; d = Cohen’s d effect size; DERS = 
Difficulties in Emotion Regulation Scale; GOALS = difficulties engaging in goal directed behaviour; HADS-A = HADS anxiety 
score; HADS-D = HADS depression score; HD = symptomatic HD group; IMPULSE = impulse control difficulties; NONACCEPT 
= non-acceptance of emotional responses; SD = standard deviation;  STRATEGIES = limited access to emotion regulation 
strategies; SUM = DERS total score; U = Mann-Whitney’s U.  
 HD Ctrl Between-group comparison Reliability 
Mean (SD) Mean (SD) U p d α 
HADS 
HADS-A 7.00 (5.80) 5.58 (2.46) 72.00 ns .318 .808 
HADS-D 8.00 (4.49) 3.00 (2.697) 27.00 .005 1.350 .805 
        
DERS 
SUM 
90.92 (28.85) 67.00 
(16.92) 
29.50 .008 1.011 .941 
NONACCEPT 12.69 (5.76) 11.42 (6.08) 63.00 ns .214 .855 
GOALS 14.00 (5.71) 10.92 (2.91) 60.00  ns .679 .814 
IMPULSE 14.54 (5.14) 9.33 (3.65) 28.50 .007 1.168 .808 
AWARE 17.54 (5.44) 14.33 (4.27) 44.50 ns .656 .763 
STRATEGIES 18.38 (6.37) 12.92 (4.14) 43.00 ns 1.016 .819 
CLARITY 13.77 (5.08) 8.08 (2.02) 30.50 .008 1.471 .775 
        
BESST 
FACES 
TOTAL 22.85 (7.06) 31.92 (4.33) 16.50 .000 -1.54 .758 
NEUTRAL 4.69 (2.50) 5.42 (1.68) 69.00 ns -.342 .634 
FEAR 2.08 (1.38) 2.58 (2.31) 71.00 ns -.262 .567 
DISGUST 2.38 (1.85) 4.50 (2.27) 34.50 .016 -1.023 .638 
HAPPINESS 7.00 (2.34) 7.92 (1.24) 63.50 ns -.491 .670 
SADNESS 1.08 (1.44) 1.92 (2.23) 62.00 ns -.447 .616 
SURPRISE 2.23 (1.73) 3.58 (1.78) 44.50 ns -.769 .531 
ANGER 3.54 (2.93) 6.00 (2.30) 40.00 .037 -.933 .756 
        
BESST 
BODIES 
TOTAL 28.15 (11.08) 39.58 (3.85) 32.00 .012 -1.378 .863 
NEUTRAL 7.00 (3.27) 9.25 (1.29) 40.50 .032 -.905 .896 
FEAR  2.62 (2.47) 5.67 (1.23) 25.00 .004 -1.563 .680 
DISGUST 1.00 (1.29) 1.75 (1.96) 62.50 ns -.452 .638 
HAPPINESS 7.54 (1.39) 7.83 (2.12) 58.00 ns -.156 .627 
SADNESS 4.62 (3.01) 7.58 (1.08) 33.00 .013 -1.309 .815 
SURPRISE 2.62 (1.61) 3.50(1.31) 54.50 ns -.599 .352 
ANGER 2.77 (2.65) 3.92 (2.27) 55.50 ns -.466 .740 




Table 2 shows the mean scores of the participants of the both the HD and 
Ctrl groups for the outcome variables, and Figure 2 provides a graphical 
illustration of the scores. All the adopted measures generally showed good levels 
of reliability. More specifically, high internal consistency was shown by HADS for 
both anxiety (Cronbach’s α = .808) and depression (Cronbach’s α = .805), as well 
as the DERS, with a Cronbach’s α of .941 for the SUM score, and figures ranging 
from .763 to .855 for the subscales. For both measures, the reliability results were 
comparable to the levels reported in the literature (Bjelland et al., 2002; Gratz & 
Roemer, 2004). With specific regards to the BESST, the total scores showed high 
internal consistency in both the facial (Cronbach’s α = .758) and emotional body 
language (Cronbach’s α = .863) modalities. The single emotions scores generally 
showed acceptable figures, with Cronbach’s α ranging between .616 and .896. 
However, low levels were found for the fear facial score (Cronbach’s α = .567), and 
for both the facial and emotional body language scores for surprise (Cronbach’s α 
= .531 and .352). 
According to the recommended clinical cut-off for the HADS (8/21; 
Bjelland et al., 2002), six of the participants of HD group (i.e., 46.15%)  showed 
clinical levels of anxiety, while seven (i.e., 53.8%) showed clinical levels of 
depression. On the other hand, only three of the participants of the Ctrl (i.e., 25%) 
group showed clinical levels of anxiety, and only one (i.e., 8.3%) reported clinical 
levels of depression. With regard to emotion regulation difficulties, the total score 
(SUM) of the HD group was significantly higher than the available data with 
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general adult populations (e.g., 77/180; Ritschel et al., 2015),  meaning that 
considerably more emotion regulation difficulties were reported by the 
participants. Instead, on average the Ctrl group scored rather lower (67/180) 
compared with the normative data.  
The general results for emotion recognition showed a slightly better 
performance on the body language modality compared to the facial one in both 
groups. However, in this study the BESST constituted quite an arduous task for all 
the participants, as rather low overall recognition rates were observed for both 
the HD group (32.6% for faces, 40.2% for bodies) and the controls (45.6% for 
faces, 56.5% for bodies). These represented lower rates compared to the ones 
reported by the validation study (i.e., 83.3/87%; Thoma et al., 2013), but were in 
line with those reported in studies that adopted the BESST with a multiple forced-
choice paradigm (e.g., 50%; Abramson et al., 2017). In terms of specific emotions, 
in the face task the least recognised emotion in both groups was sadness (HD: 
10.8%, Ctrl: 19.2%), while the most easily identified was happiness (HD: 70%, Ctrl: 
92.5%). The results on these two emotions were in line with the findings of the 
validation study. On the other hand, in the body language modality the lowest 
scores were observed on disgust for both groups (HD: 10%, Ctrl: 17.5%), while the 
highest were again on happiness (HD: 75.4%, Ctrl: 78.3%), along with neutral 
stimuli (HD: 70%, Ctrl: 92.5%). Contrarily to the facial modality, this result was 
opposite to the validation data, which found happiness body stimuli to be least 
recognised. 
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The group comparison analysis showed that the participants affected by 
HD had a significantly greater level of depression when compared to the controls 
(U = 27.0, z = -2.787, p = .005); however, no significant difference was found for 
anxiety levels (U = 72.0, z = -.328, p = ns). In terms of emotion regulation, a 
significantly greater level of total difficulties (DERS SUM) was reported by the HD 
group (U = 29.5, z = -2.639, p = .008). In this regard, the effect size analysis showed 
a very large group effect on the overall scores for emotion regulation (d = 1.011), 
facial emotion recognition (d = -1.54), and emotional body language recognition 
(d = -1.378). When comparing the specific components of the DERS, significant 
differences were observed on impulse control difficulties (IMPULSE; U = 28.5, z = 
-2.730, p = .007), and lack of emotional clarity (CLARITY; U = 30.5, z = -2.595, p = 
.008). With regard to emotion recognition, the overall performance of the HD 
group on the BESST was significantly poorer for both the facial (U = 16.5, z = -
3.352, p < .000) and body language (U = 32.0, z = -2.510, p = .012) modalities. In 
terms of specific emotions, the facial modality revealed specifically greater 
impairments in the HD group for disgust (U = 34.5, z = -2.402, p = .016) and anger 
(U = 42.0, z = -2.082, p = .012), while the body language modality yielded poorer 
performances for fear (U = 25.0, z = -2.914, p = .004), sadness (U = 33.0, z = -2.481, 
p = .013), and neutral stimuli (U = 32.0, z = -2.144, p = .012).  However, in spite of 
a lack of statistical significance, several medium to large effect sizes were observed 
for specific components of the outcome variables, thus showing group effects at a 
trend level. These included limited access to regulation strategies (STRATEGIES; d 
= 1.016), difficulties in engaging in goal directed behaviour (DERS GOALS; d = 
.679), lack of emotional awareness (DERS AWARE; d = .656), facial recognition of 
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happiness (d = -.491), sadness (d = -447), and surprise (d = -.769), as well as body 
language recognition of disgust (d = -.452), surprise (d = -.599), and anger (d = -
.466). 
Table 3 
Spearman's correlation coefficients for the HD group (N = 13) across the main variables. 
 1 2 3 4 5 6 7 8 9 10 11 
1. Gender            
2. Age .112           
3. Education (yrs) .342 -.127          
4. Diagnosis (yrs) -.272 .121 -.073         
5. TFC Score .271 .326 .092 .125        
6. HD Stage -.501 -.323 -.325 -.025 -.902**       
7. HADS_A .022 -.032 -.220 -.204 -.301 .260      
8. HADS_D -.201 .170 -.135 -.222 -.593* .558* .510     
9. DERS_SUM .089 .132 -.316 -.168 -.421 .371 .905** .629*    
10. BESST_F_SUM .157 -.213 .296 -.345 .393 -.533 .025 .015 -.168   
11. BESST_B_SUM .491 -.077 .320 -.238 .521 -.675* -.207 -.259 -.300 .739**  
Note. * = p<.05; ** = p<.01; BESST = Bochum Emotional Stimulus Set; BESST_B_SUM = BESST Bodies 
total score; BESST_F_SUM = BESST Faces total score; DERS = Difficulties in Emotion Regulation 
Scale; DERS_SUM = DERS total score; HADS = Hospital Anxiety and Depression Scale; HADS_A = 
HADS anxiety score; HADS_D = HADS depression score; HD = Huntington’s disease; TFC = Total 
Functional Capacity; yrs = years. 
 
In light of the significant differences observed in symptomatic individuals 
on the group comparison, a correlation analysis was carried out to explore 
whether the impairments on emotion regulation and recognition in the HD group 
were correlated with the demographic characteristics and the measures of 
psychological difficulties. Table 3 illustrates Spearman’s coefficients for the 
correlation analysis of the HD group among the main variables; Table 4 instead 
illustrates the correlation coefficients among all the variables, including the 
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respective subscales. The results showed that the overall level of emotion 
regulation difficulties (DERS_SUM) shared a very strong positive correlation with 
levels of anxiety (HADS_A; rs = .905, p < .001), as well as a strong correlation with 
levels of depression (HADS_D; rs = .629, p = .021). In particular, the two 
components that were specifically impaired in the HD group, IMPULSE and 
CLARITY, were respectively related to anxiety (rs = .675, p = .011) and depression 
(rs = .717, p = .006). With regard to emotion recognition, the overall performance 
for the facial modality of the BESST (BESST_F_SUM) was strongly correlated with 
the overall performance for the body language modality (BESST_B_SUM; rs = .739, 
p < .001), confirming the relationship between the two emotion recognition 
components. This was also confirmed by the observation of significant 
relationships across the modalities between the single scores for neutral stimuli 
(rs = .606, p = .028), disgust (rs = .582, p = .037), and anger (rs = .589, p = .034), as 
well as linear trends close to significance for fear (rs = .526 p = .065) and surprise 
(rs = .499, p = .082). In addition, the total score for the body language modality 
(BESST_B_SUM) shared a strongly significant negative relationship with HD stage 
(rs = -.675, p = .011), meaning that the recognition of emotional body language of 
the participants affected by HD deteriorated in line with disease progression. The 
total score for the facial modality (BESST_F_SUM), showed a similar trend towards 
HD stage (rs = -.533, p = .060). 
Discussion 
This aim of this study was to investigate whether emotion regulation and 
emotional body language (EBL) recognition are impaired in people with 
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symptomatic HD when compared to age-matched controls, and whether such 
impairments share a significant relationship to one another. In addition, to our 
knowledge this was the first study with this specific population to explore emotion 
regulation along with emotion recognition, as well as both facial and EBL 
recognition modalities together. The results showed significant impairments for 
the HD group in emotion regulation, as well as emotion recognition in both the 
facial and EBL modality. This was in line with our initial predictions and confirmed 
our first two hypotheses.  
In terms of specific components of emotion regulation, significant results 
were found for impulse control difficulties (DERS IMPULSE) and lack of emotional 
clarity (DERS CLARITY). This appears to be consistent with several previous 
observations of impulse control and executive functioning deficits in people with 
HD (Duff et al., 2010; Galvez et al., 2017; Gray et al., 2013; Mörkl et al., 2016), that 
are often due to the impact of the disease on prefrontal brain areas (Dogan et al., 
2014; Gray et al., 2013) and are likely to play a pivotal role in the clarity and 
control of emotional experiences. No significant differences were observed for the 
remaining components of emotion regulation, including DERS STRATEGIES. This 
particular finding was in line with the only other study on emotion regulation in 
people with HD, which only explored the use of regulatory strategies and found no 
significant differences with age-matched controls (Croft et al., 2014). In addition, 
since no authors have previously carried out a comprehensive investigation of 
emotion regulation in HD which includes all its components, the significant 
difference on the DERS SUM observed in this study represents the first evidence 
of a general impairment of emotion regulation in this specific population.  
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The observed impairment for facial emotion recognition adds further 
confirmation to the already well-known deficit reported in the literature (for a 
review, see Bates, Tabrizi, & Jones, 2014). Moreover, the results on the single 
emotion scores also confirmed the known specific deficit of negative emotions 
such as disgust and anger, even though no specific difference was found for the 
facial recognition of fear and sadness. The impairment on the EBL modality was 
partially in line with the only other study that investigated this construct in people 
with symptomatic HD, that found a significant impairment for the recognition of 
anger and emotionally neutral instrumental stimuli, but no deficit for fear and 
sadness (de Gelder et al., 2008). Indeed, a specific impairment for neutral (yet not 
instrumental) stimuli was found in the present study too. However, the 
comparisons on the single emotion scores yielded almost opposite results, with a 
significant impairment for fear and sadness, but no significant deficit for anger. As 
the above mentioned study did not include stimuli for happiness, surprise, and 
disgust, it is not possible to know whether other emotions were impaired, and to 
what extent our results differ. As a consequence, the finding of the present study 
also represents the first evidence of an impairment of emotional body language 
(EBL) recognition in people with symptomatic HD through a comprehensive 
assessment that includes both positive and negative emotional stimuli. 
With regards to the relationship between emotion regulation and emotion 
recognition, the correlation analysis showed that the observed impairments did 
not significantly relate with each other. This result went against our predictions, 
and contradicted our third hypothesis. Moreover, it was also inconsistent with 
what  was previously reported in other clinical populations, such as anorexia 
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nervosa (Harrison et al., 2009). On the other hand, the overall level of emotion 
regulation difficulties shared a significant correlation with anxiety and depression. 
In addition, impulse control difficulties and lack of emotional clarity – the two 
emotion regulation components that were specifically impaired in the HD group – 
shared significant relationships with anxiety and depression respectively. These 
findings suggest that, in the participants of the HD group, anxiety and depression 
might have played a pivotal role in the operationalisation of emotion regulation. 
Moreover, they are consistent with previous reports of associations between 
mood and anxiety problems and deficits of emotion regulation (e.g., Ehring et al., 
2008; Loas et al., 1997; for a review on anxiety, see Cisler, Olatunji, Feldner, & 
Forsyth, 2010), and in particular between impulse control and anxiety  (e.g., with 
Parkinson’s disease; Voon et al., 2011), and emotional clarity and depression 
(Dixon-Gordon et al., 2014; Thompson, Boden, & Gotlib, 2017).  Thus, the 
significant difference on the DERS in the HD group when compared to the Ctrl 
group may represent a reflection of the significantly higher level of depression 
reported by the symptomatic participants.  
As mentioned above, some of the findings of this study appear to 
contradict what has been previously reported in the literature. In particular, the 
results on the single emotion scores of the BESST showed no deficits for the facial 
recognition of fear and sadness, and the EBL recognition of anger. While some of 
these inconsistencies may be due to the use of different measures – especially as 
the BESST has never been adopted before with HD and may not represent the most 
well-fitting measure with this population – as well as differences in the way the 
stimuli were administered, an important caveat to be noted is the potential effect 
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of the relatively small sample size. Indeed, the effect size analysis showed that 
most of those inconsistent results in fact represented differences at a trend level 
characterised by medium to large effect sizes (d = -.452 – 1.016). Moreover, this 
could be also applied to some of the results of the correlation analysis that were 
approaching significance, such as the correlation between facial emotion 
recognition and HD stage. Thus, it could be hypothesised that the adoption of a 
larger sample would yield significant differences on fear, sadness, and anger in line 
with the findings in the previous literature, as well as significant correlations in 
line with the ones that were found in this study.  
Limitations and future directions 
A number of limitations should be considered along with the results of this 
study. First, as the data were collected through single sessions at the participants’ 
home, it was not possible to perform any cognitive screening prior to the 
administration of the research materials. While this allowed the cognitive load to 
a comfortable level, it also prevented a more precise understanding of the 
participants’ level of cognitive functioning, which would have allowed for a better 
clinical depiction of the stage of disease. Moreover, some participants required the 
experimenter to record their responses of their behalf, thus adding a possible 
source of misunderstanding. Secondly, the participants in the control group were 
recruited from partners and caregivers of people with HD. While this facilitated 
the selection of a sample from a population matching the HD group in terms of age 
and education, it did not support the assumption that the observations were 
completely independent. Thirdly, the generally low recognition rates on the BESST 
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showed that the emotion recognition tasks were rather difficult for both the HD 
and Ctrl group as compared to the available normative data. This is likely due to 
the differences in the way the tasks were administered compared to the validation 
study (Thoma et al., 2013), which was based on a two-alternative forced choice 
task with a 3000ms limit, while the present study featured a six-alternative forced 
choice task with no time limit. Indeed, lower recognition rates were reported 
when adopting the BESST with tasks based on four or more alternatives 
(Abramson et al., 2017), which currently represents the golden standard of some 
of the most widely adopted facial and EBL emotion recognition tests (e.g., Reading 
the Mind in the Eye test – RME, Baron-Cohen et al., 2001; Bodily Expressive Action 
Stimulus Test - BEAST, de Gelder & Van den Stock, 2011; CANTAB Emotion 
Recognition Task, Sahakian & Owen, 1992; Ekman 60 Faces Test, Ekman, Friesen, 
1976; Emotion Hexagon Task Calder et al., 1996). In addition, the general better 
performance observed in both groups on the EBL recognition component as 
opposed to the facial one may be due to an effect of the order of presentation of 
the tasks (facial first, EBL second), which was kept constant among the 
participants. Last, despite being in line with most of the current studies on emotion 
recognition in HD (Bates, Tabrizi, & Jones, 2014), the sample size in this study was 
relatively limited. This translated into a number of variables that showed 
differences between the groups at a trend level, but that were not statistically 
significant. Moreover, the small sample size did not allow to control whether 
depression levels predicted emotion regulation difficulties. Thus, the conclusion 
that HD directly impacts emotion regulation should be taken cautiously until 
additional evidence is obtained with larger samples. 
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Future research should aim at further exploring emotion regulation and 
emotion recognition in larger samples of people with symptomatic HD, as well as 
obtaining a better understanding of the potential relationship between these two 
constructs. Other measures of EBL recognition should also be adopted with HD 
populations, in order to control for the external validity of the BESST and to build 
a comprehensive corpus of data similar to the one currently available for facial 
stimuli. In particular, more data are warranted on the optimal use of the BESST 
stimuli when based on a multiple-choice forced task, in order to avoid potential 
floor effects on the participants’ performances. In this perspective, the adoption of 
EBL measures would benefit from the inclusion in large multi-centre studies, 
which would also allow to integrate in-depth general cognitive screenings.  
Conclusion  
This study shed new light on emotional processing in people with 
symptomatic Huntington’s disease by providing multi-componential evidence that 
emotion regulation and emotional body language (EBL) recognition are 
significantly impaired in this population, and that the latter is negatively related 
to the stage of disease. It also provided the first evidence of a significant direct 
correlation between deficits of facial and body language emotion recognition in 
HD, although emotion regulation and emotion recognition were not related.  
These findings have important implications for clinical practice, as a more 
in-depth understanding of emotional processing in HD has the potential to revise 
current therapeutic and communicative protocols, as well as informing new ones. 
More specifically, better insight into emotion regulation issues in this population, 
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along with their connections to mood and anxiety disorders, would allow the 
development of psychological and pharmacological interventions that are tailored 
around the emotional needs of each patient. 
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Spearman's correlation coefficients for the HD group across all the variables. 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 
1 
GENDER                               
 
2 
AGE .112                              
 
3 
EDUCATION (YRS) .342 -.127                             
 
4  
DIAGNOSIS  (YRS) -.272 .121 -.073                            
 
5  
TFC SCORE .271 .326 .092 .125                           
 
6  
HD STAGE -.501 -.323 -.325 -.025 -.902**                          
 
7  
HADS_A .022 -.032 -.220 -.204 -.301 .260                         
 
8  
HADS_D -.201 .170 -.135 -.222 -.593* .558* .510                        
 
9 
DERS_SUM .089 .132 -.316 -.168 -.421 .371 .905** .629*                       
 
10 
DERS_NONACCEPT -.067 .029 -.568* -.017 -.441 .484 .739** .404 .878**                      
 
11  
DERS_GOALS .291 -.035 -.218 -.267 -.355 .279 .867** .436 .919** .770**                     
 
12  
DERS_IMPULSE .067 .191 -.396 -.267 -.214 .223 .717** .457 .866** .857** .787**                    
 
13  
DERS_AWARE .134 -.059 .163 -.548 -.453 .334 .383 .825** .437 .124 .358 .265                   
 
14 
DERS_STRATEGIES -.067 .170 -.425 .109 -.550 .558* .765** .632* .916** .861** .823** .724** .301                  
 
15  
DERS_CLARITY -.112 .250 .109 -.371 -.459 .491 .351 .687** .456 .313 .309 .456 .611* .412                 
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 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 
16 
BESST_F_SUM .157 -.213 .296 -.345 .393 -.533 .025 .015 -.168 -.404 -.101 -.082 .287 -.434 -.264                
 
17 
BESST_F_NEUTRAL .383 -.440 .204 -.492 -.080 -.156 -.241 -.211 -.239 -.218 -.156 -.221 .233 -.427 -.299 .377               
 
18 
BESST_F_FEAR .275 -.264 -.157 -.121 .238 -.248 -.259 -.286 -.342 -.312 -.095 -.305 -.184 -.321 -.595* .364 .216              
 
19 
BESST_F_DISGUST .092 -.347 .382 -.216 .408 -.529 .088 -.178 -.179 -.419 -.037 -.159 .105 -.410 -.376 .902** .293 .273             
 
20 
BESST_F_HAPPNSS -.519 -.023 -.249 -.142 .263 -.092 -.257 .018 -.274 -.167 -.421 -.070 -.023 -.357 -.182 .357 .106 .126 .219            
 
21 
BESST_F_SADNESS .310 .131 .248 -.030 -.077 -.040 .079 .590* .115 -.155 .022 -.049 .678* .078 .285 .356 .036 .086 .089 -.143           
 
22 
BESST_F_SUPRISE .271 .197 .375 -.465 -.037 -.207 .254 .338 .206 -.185 .328 .181 .443 .064 .248 .521 .023 .109 .499 -.216 .279          
 
23  
BESST_F_ANGER -.249 -.086 -.029 .136 .099 -.069 .604* .376 .458 .282 .382 .386 .196 .339 -.013 .475 -.359 -.017 .496 .290 .220 .217         
 
24  
BESST_B_SUM .491 -.077 .320 -.238 .521 -.675* -.207 -.259 -.300 -.511 -.080 -.266 .025 -.458 -.546 .739** .357 .700** .691** .204 .215 .456 .212        
 
25 
BESST_B_NEUTRAL .409 -.427 .138 -.111 .223 -.322 -.431 -.549 -.429 -.377 -.179 -.441 -.208 -.456 -.731** .235 .653* .606* .311 .119 -.198 -.100 -.275 .654*       
 
26 
BESST_B_FEAR .551 .261 .309 -.199 .759** -.878** -.298 -.396 -.342 -.499 -.179 -.171 -.167 -.524 -.447 .612* .212 .526 .530 .204 .111 .397 .086 .888** .473      
 
27 
BESST_B_DISGUST .195 -.006 .069 -.266 .287 -.420 .410 .018 .151 -.009 .194 .215 .090 -.089 -.036 .656* .037 .212 .582* -.109 .245 .494 .418 .314 -.251 .340     
 
28 
BESST_B_HAPPNSS -.185 -.327 .081 -.291 -.261 .167 .286 .330 .051 -.190 .103 -.276 .424 .009 -.121 .408 .191 .330 .440 .188 .217 .343 .358 .344 .181 -.006 .210    
 
29 
BESST_B_SADNESS .365 .208 .190 -.083 .496 -.653* -.137 -.044 -.172 -.438 -.051 -.167 .085 -.272 -.466 .713** .156 .567* .628* .203 .335 .568* .317 .910** .424 .835** .337 .328   
 
30 
BESST_B_SURPRISE .578* .036 .747** -.012 .077 -.372 -.069 .165 -.077 -.383 -.011 -.189 .370 -.175 .047 .462 .185 .140 .347 -.332 .718** .499 .154 .509 .096 .448 .303 .119 .507  
 
31 
BESST_B_ANGER .248 -.109 -.055 -.054 .582* -.470 .158 -.127 .089 -.008 .236 .222 -.038 -.064 -.331 .531 -.114 .455 .530 .313 .094 .119 .589* .648* .303 .603* .255 .041 .574* .137 
 
Note. * = p<.05; ** = p<.01; AWARE = lack of emotional awareness; BESST = Bochum Emotional Stimulus Set; BESST_B = BESST Bodies modality; BESST_F = BESST Faces modality; CLARITY = lack of emotional clarity; Ctrl = control 
group; DERS = Difficulties in Emotion Regulation Scale; GOALS = difficulties engaging in goal directed behaviour; HADS = Hospital Anxiety and Depression Scale; HADS-A = HADS anxiety score; HADS-D = HADS depression score; HD 
= Huntington’s disease; IMPULSE = impulse control difficulties; NONACCEPT = non-acceptance of emotional responses; STRATEGIES = limited access to emotion regulation strategies; SUM = total score; TFC = Total Functional 
Capacity; yrs = years. 
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Chapter 7  
 
General Discussion  
Overview 
This chapter serves to present an integration of the findings of the studies 
of the present thesis, as well as to highlight theoretical and practical implications 
and limitations. The overall aim of this research project was to investigate the 
impact of Huntington’s disease (HD) on the communication of affected individuals. 
Communication was here intended and operationalised as the heterogeneous 
ability that “focuses on how people use messages to generate meanings within and 
across various contexts, cultures, channels, and media” (Korn, Morreale, & Boileau, 
2000, p. 40), thus including nonverbal components such as emotional processing 
and body language. Based on the research question, and in accordance with the 
critical realist position of the researcher, it was reasoned that the adoption of a 
mixed methods design would allow for a better investigation of the heterogeneity 
of the construct of communication (Frost & Shaw, 2015). This in turn informed the 
choice of a methodological framework characterised by a sequence of studies that, 
although equal in terms of methods importance, were designed with the purpose 
of allowing the initial investigations to inform the later ones (i.e., development; 
Greene, 2007; Greene et al., 1989). As a consequence, within the context of the 
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abovementioned overall aim of the research project, each study (or publishable 
paper, PP) led to the development of further, more specific research aims. 
Review of research aims and summary of main findings 
Research aim 1: to identify the elements of communication and 
methodological approaches investigated in symptomatic HD 
The first specific research aim was to explore the breadth of elements of 
communication that had already been investigated in people with symptomatic 
HD, along with the diversity of adopted methodological approaches. This was 
addressed through a scoping review of the empirical quantitative and qualitative 
literature (PP1). The search identified 49 eligible citations, which were then 
divided into four categories: Communicative Skills, Emotion, Language, and 
Speech. Out of these categories, the most investigated elements of communication 
were facial emotion recognition, the assessment of linguistic productive abilities, 
and speech assessment. As a consequence, the most adopted methods were visual 
recognition tasks of emotional facial pictures, as well as cognitive language and 
speech examinations. The result was in line with a systematic review of the 
literature of emotion recognition in HD (Henley et al., 2012), which identified an 
underrepresentation of methods aimed at exploring non-facial features of 
emotional processing, such as body language.  
Much less investigated topics identified by the scoping review included 
emotion expression, language comprehension, and therapeutic interventions on 
communication or speech. However, the topic that was by far recognised as the 
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most neglected in the literature was the subjective perspectives of people with 
Huntington’s disease on their communicative skills and functioning, with only two 
retrieved studies addressing them. This confirmed an already known 
underrepresentation of first person perspectives explorations in all chronic 
illnesses which cause communicative impairments, such as stroke, Parkinson’s 
disease, and motor neuron disease (Mistry & Simpson, 2013; Thorne et al., 2002). 
Moreover, with specific regard to HD, this finding was in accordance with a general 
lack of qualitative investigations in Huntington’s that was recently observed by a 
review of the qualitative literature in neurodegenerative conditions (Audulv et al., 
2014). However, the results of the two identified studies on communication 
perspective in people with HD shed important preliminary light on the importance 
of many social and environmental factors on communication (Hartelius, Jonsson, 
Rickeberg, & Laakso, 2010; Power, Anderson, & Togher, 2011). In addition, they 
showed the potential for a qualitative subjective approach to communication in 
HD to highlight aspects and issues that may go overlooked with the adoption of 
quantitative methods alone, thus informing the development of the following 
study of this thesis.  
Research aim 2: to explore the perspectives on communication in 
people with symptomatic HD 
The initial scoping literature review (PP1) highlighted the need for further 
explorations of subjective experiences and perspectives of people affected by 
Huntington’s disease on their communicative skills. As a consequence, this topic 
was addressed with a qualitative study based on semi-structured interviews 
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analysed through thematic analysis (PP2). The results identified four main 
recurring themes among the participants’ accounts. The first theme concerned the 
directing and mediating role of HD within the context of the participants’ everyday 
communication, by blocking their speaking abilities directly or causing conditions 
that influence their experience in more indirect ways (e.g., chronic fatigue). The 
identification of HD’s influence led the way to the second theme, which was 
characterised by the need to retake control over the features of communication as 
an effective coping strategy. Examples of this included having a choice over 
demanding things that require particular energy, such as answering the phone or 
participating actively in conversations.  
The third theme concerned the impact of HD on the emotional life of the 
participants, and how it makes it unstable. This included inconsistent emotional 
states characterised by anger or sadness, often accompanied by considerably 
longer recovery times, which ultimately caused a pervasive feeling of emotional 
unsteadiness. With regard to this, an improvement in emotion regulation was 
identified as a potential solution. Indeed, despite being a challenging process that 
often required engaging with difficult and disturbing thoughts, the achievement of 
a better regulation of emotional responses led to considerably increased 
willingness to communicate. Moreover, this process was reported to be 
particularly enhanced by the development of a supportive network consisting of 
close relationships with family member and friends, as well as by the 
implementation of effective medication regimes. 
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The fourth theme concerned the in-depth exploration of a particular 
coping strategy that was mentioned by many participants, and that consisted in 
the idea of owning a personal safe place (sheltering). Although being initially 
identified with their home, this idea later extended to a more abstract conception 
of safety, a mind ‘shelter’ where the participants could feel safe to switch off from 
the world. In particular, this not only seemed to help them deal with everyday 
challenges, but also appeared to boost their self-confidence in the process of 
managing emotions observed in the previous theme, further underlining the 
importance of the successful operationalisation of emotion regulation.  
Research aim 3: to investigate how HD affects emotion regulation 
abilities and how they relate to emotion recognition 
As outlined by the findings of the qualitative study (PP2), the ability to 
regulate emotions efficiently can be of paramount importance in the psychological 
adaptation to HD, in particular within the context of communication. However, the 
results of the initial scoping review had shown no quantitative investigations on 
whether emotion regulation is affected by HD, nor whether this construct relates 
in any way to the deficit of emotion recognition caused by the disease. Thus, this 
aim was addressed with two parallel quantitative studies, in order to target both 
presymptomatic (PP3) and symptomatic (PP4) individuals. The latter study also 
included a body language emotion recognition task, in order to address one of the 
neglected areas in emotional processing in HD identified by PP1.  
In general, the results showed that emotion regulation and recognition 
were not affected by HD in presymptomatic individuals, while significant 
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impairments were found for both in symptomatic people. This included a deficit of 
EBL recognition in PP4, which was significantly related to the impairment on the 
facial tasks. This not only confirmed the well-known facial recognition impairment 
which is observed in symptomatic HD (Henley et al., 2012; Novak & Tabrizi, 2005), 
but also confirmed the close connection between these two components of 
emotional processing (de Gelder & Hortensius, 2014). Within both populations, 
however, no significant correlation was observed between emotion regulation and 
recognition. This appeared to be inconsistent with the current evidence with other 
clinical populations such as anorexia nervosa, in which a significant relationship 
was reported (Harrison, Sullivan, Tchanturia, & Treasure, 2009). Nonetheless, the 
findings from PP2 showed that presymptomatic individuals had a specific 
impairment of the emotional awareness component of emotion regulation 
originating from the association with subclinical depressive symptoms, and this 
was proposed to represent a precursor of the emotion recognition impairment 
later found in fully symptomatic HD. Within this perspective, it could be 
hypothesised that the relationship between emotion regulation and recognition in 
Huntington’s disease may not consist of a presentation of linearly associated 
impairments as in other populations. Instead, it may be acting as an earlier and 
more cyclical process, with some deficits on specific elements of emotion 
regulation playing a pivotal role along depressive symptoms in the development 
of emotion recognition impairments, which in turn affects other elements of 
emotion regulation in the long term. 
 




Levels of integration 
Within the context of mixed-methods research, a particularly debated 
subject is at what point different methods should be actually integrated to achieve 
a logic and consistent account of the research findings (Fetters, Curry, & Creswell, 
2013). A possible solution is the categorisation outlined by Moran-Ellis and 
colleagues (2006). In particular, the authors argue that the concept of integration 
(as opposed to simple combination) of methods requires that the status of all 
utilised methods is equal in standing, and that they all aim at a common goal while 
retaining their paradigmatic features. This leads to three possible levels of 
integration: a) integrated methods, i.e. when integration occurs at the design (or 
methods) level; b) separate methods, integrated analysis, i.e. when the integration 
occurs during the analytical process; c) separate methods, separate analysis, 
theoretical integration, i.e. when the data of the studies are analysed within the 
parameter of their respective paradigms, and later integrated within a single 
explanatory or interpretive framework. In consideration of the abovementioned 
purpose, timing, dependence, status, and methods of the studies (Greene, 2007; 
Greene et al., 1989), a theoretical integration was reasoned to be most adequate 
for the work of the present thesis, as it would allow to reflect the heterogeneity of 
the different methods and designs involved in the research process (Moran & 
Butler, 2001). In particular, in the view of integrating the present findings at a 
theoretical level within the field of health psychology, an interpretive framework 
that proved to fit especially well with the diverse range of methods of this work is 
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represented by the already mentioned ‘common sense’ self-regulation model 
(SRM; Leventhal, Leventhal, & Contrada, 1998). 
The self-regulation model (SRM) 
According to the SRM, an individual’s psychological adaptation to health 
threats – and especially chronic conditions – is based on their own lay (‘common 
sense’) perspectives about illnesses (Leventhal, Leventhal, & Brissette, 2003). 
More specifically, adjustment is seen as a function of cognitive and emotional 
representations that, working as parallel processes, lead to the adoption (or 
avoidance) of specific coping strategies, which in turn interact with adjustment 
itself (Hagger et al., 2017).  
In particular, the content of cognitive representations can be divided into 
six dimensions (Moss-Morris, Humphrey, Johnson, & Petrie, 2007): a) identity, i.e. 
the illness ‘label’ and the number of symptoms attributable to it; b) timeline, i.e. 
perceptions on the time, onset, duration, and development of the condition; c) 
cause, i.e. the individual’s perception on what caused the illness; d) consequence, 
i.e. individuals’ beliefs on the impact the condition on their everyday life; e) 
perceived control, i.e. perceptions on individuals’ capacity to influence the course 
of the illness; f) illness coherence, i.e. individuals’ understanding of their own 
condition. On the other hand, emotional representations are related to the 
adoption of coping procedures aimed at managing the psychological distress 
related to process of becoming ill (e.g., anxiety and/or depression), as well as any 
psychological difficulties directly caused by the illness itself (Hagger et al., 2017). 
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In fact, a key dimension of the emotional representations arm of the model 
is represented by emotion regulation, whose successful operationalisation is 
essential for the management of illness-related distress (Leventhal et al., 2003). In 
this perspective, an expanded version of the SRM has been proposed, which 
underlines the importance of the emotion regulation strategies outlined by Gross 
(1998; 2015) by integrating them into the SRM (Cameron & Jago, 2008). As Figure 
3 illustrates, the manifestation of illness stimuli leads to the development of the 
two types of illness representations, cognitive and emotional, which in turn 
manage the adoption of cognitive and emotional regulatory (ER) coping strategies. 
Both processes end with an appraisal of the coping success, which then leads to a 
reappraisal of the illness stimuli. It is important to note that, despite being parallel 
processes, the cognitive and emotional arms of the model can affect each other in 
a number of ways, both positive and negative. For example, the development of 
coherent cognitive representations and strategies may help lower the impact of 
excessive emotional representations (e.g., excessive anxiety or fear) and prevent 
the adoption of counterproductive emotional regulatory strategies, such as 
emotion avoidance and suppression. Similarly, the successful implementation of 
emotional representations and regulatory strategies may help prevent incautious 
cognitive representations leading to dangerous coping strategies (e.g., 
minimization of symptoms leading to avoidance of treatment). It is also essential 
to note that the whole system is in constant interaction with the social setting of 
the individual, which has the potential of affecting deeply the choice of coping 
strategies, as well as their success, thus mediating the outcome of both the 
abovementioned processes (Leventhal, Diefenbach, & Leventhal, 1992). 




Figure 5: Expanded SRM including emotion regulation (ER) strategies (adapted from 
Cameron & Jago, 2008). 
Theoretical integration within the expanded SRM 
Due to its focus on emotion regulation, the expanded version the SRM 
(Cameron & Jago, 2008) appears to represent a particularly well-fitting  
interpretive framework for the integration of the findings of this thesis, even more 
than Leventhal’s original model (1998). In this perspective, the findings of each of 
the PPs following the scoping review (PP1) can be related directly with the 
components of the model, allowing them to be interpreted altogether despite the 
different methodologies of the studies. More specifically, they can be viewed as 
providing insight into specific components that, if successfully operated, can 
support the development and maintenance of two adaptive circles involving 
cognitive and emotional coping strategies, as well as social and environmental 
elements (see Figure 4).  




Figure 6: Theoretical integration of the findings of the publishable papers (PPs) within the framework of the expanded SRM (adapted from 
Cameron & Jago, 2008). The SRM is shown in black, while the PPs integration is shown in red. The proposed adaptive circles are indicated in 
blue (cognitive coping strategies  ER coping strategies) and green (cognitive coping strategies  social setting).  
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On one side, the perspectives of people with Huntington’s disease outlined 
in PP2 shed important light on how HD’s symptomatology (identity) has a severe 
impact on every aspect of communication, from speech to memory and fatigue, 
also including emotional processing (emotional representations), and in particular 
aspects such as emotional and mood reactions (anxiety, fear, worry). This brought 
to attention a need for regaining control over communication (control) that, if 
successfully implemented, could lead to the development of efficient cognitive 
coping strategies such as sheltering (changing health habits). In turn, these showed 
the potential to help enhance emotion regulation strategies, and in particular the 
management of emotional reactions (response modulation), which most of the 
participants found particularly challenging due to the emotional instability caused 
by the disease. As a consequence, success at regulating emotions also allowed for 
the reinforcement of those healthier behavioural and communicative habits, thus 
enabling an adaptive circle between cognitive coping strategies and ER coping 
strategies, in particular between the changing health habits and response 
modulation components.  
Similarly, a parallel contribution towards this circle was provided by the 
findings of PP2 and PP3, which shed new light on the impact of HD on emotional 
processing (emotional representations) at both the symptomatic and 
presymptomatic stage. In particular, they also showed how the disease may affect 
emotions not only by disrupting their stability directly, but also through the 
association with concurrent depressive symptoms (worry), which can help disrupt 
specific components of emotional processing (e.g., emotional awareness). As a 
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result, the combination of these associations will eventually lead to a greater 
impairment of emotion regulatory skills (response modulation). Therefore, the 
findings of PP2 and PP3 suggest that, by targeting interventions at the specific 
elements (emotional representations, and in particular worry) that have shown to 
contribute to the emotional upheaval caused by HD, the detrimental effect on 
response modulation may be reversed. As observed with the results of PP2, this has 
in turn the potential to help towards the development of an adaptive circle 
between cognitive and emotional coping strategies.     
On the other side, the findings of PP2 were also helpful in underlining the 
importance of social and environmental factors (social setting), and their effect on 
communication and emotional processing in people with HD. In particular, many 
participants recognised the pivotal role played by the support of family members 
and friends in helping them deal with the everyday challenges of the disease. This 
translated into a beneficial effect on the motivation to search and ask for support 
when needed (seeking information), as well as on the uptake of effective 
medication regimes (use of treatments). In turn, this had the potential to improve 
communication and thus interpersonal interactions in general, with an overall 
beneficial effect on the social and environmental context. As a consequence, this 
may help the development of a second adaptive circle, this time between cognitive 
coping strategies (in particular the seeking information and use of treatments 
components) and social setting. 
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As outlined in the previous chapter, the theoretical integration of the 
present findings relies on the prospective development of two adaptive circles 
based on specific cognitive, emotional, and social components of the expanded 
SRM. This carries the potential to deepen our theoretical understanding of how 
cognition and emotion work in people affected by Huntington’s disease. In 
particular, the adoption of a mixed-methods approach has helped to unearth and 
highlight the importance for mental health of the relationship between specific 
elements of emotional processing and communication that have been so far 
neglected in the empirical literature, especially the combined role of emotion 
regulation and emotion recognition. This answered a current general need for 
investigations focused on the relationship between different emotional 
components – as opposed to traditional studies targeting them independently – in 
order to achieve a better understanding of their combined effects on health (see 
Pandey & Choubey, 2010 for a review). More specifically, the present findings also 
offer additional theoretical insight and renewed momentum into the currently 
recognised need for further explorations focused on understanding the 
psychological issues and difficulties of living with HD (Audulv et al., 2014). 
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Implications for clinical practice 
The results of the present research also feature practical implications for 
the field of health psychology, as they carry the potential to inform the 
development of interventions tailored around specific cognitive and emotional 
needs of patients with HD. Indeed, the possibility of enhancing patients’ cognitive 
reserves through cognitive training interventions has proven to be a very 
promising approach to delay or control the onset of symptoms in 
neurodegenerative diseases (Papoutsi, Labuschagne, Tabrizi, & Stout, 2014). With 
regard to this, however, the current literature seems to be characterised by a 
significant paucity of studies addressing cognitive interventions in HD, and there 
is currently a strong need for further investigations in this area (for a review, see 
Andrews, Dominguez, Mercieca, Georgiou-Karistianis, & Stout, 2015). For 
instance, recent preliminary evidence suggests that addressing emotion 
recognition impairments at both presymptomatic and early stage via self-guided 
computerised training can lead to significant improvement in accuracy, opening 
up new avenues for innovative methods of intervention (Kempnich, Wong, 
Georgiou-Karistianis, & Stout, 2017). Moreover, the case of HD represents an ideal 
model for the exploration of this kind of interventions, particularly thanks to its 
genetic nature, the availability of predictive testing, and the consequent well-
established underlying pathological mechanisms (Papoutsi et al., 2014).  
However, in addition to individual cognitive training, the present findings 
can help focus on other promising areas of development. For example, the 
observation of coping strategies such as sheltering – as well as the importance of 
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environmental and relational factors such as effective support from friends and 
family members – carry the potential to help inform a more systemic approach to 
intervention. Indeed, current evidence shows that interventions based on social 
models of disability aimed at reducing negative interactions (such as those 
characterised by stigma) may contribute considerably to preventing negative 
emotions and tendencies to reduced social participation (Simpson, McMillan, & 
Reeve, 2013) – which represent the basis of a phenomenon that has recently been 
defined as psychoemotional disablism (Reeve, 2012). With specific regards to the 
current result, examples of this kind of interventions may include the 
enhancement of sheltering through group meditation (e.g., mindfulness-based 
programs; Chan, Churcher Clarke, Royan, Stott, & Spector, 2017),  the adoption of 
less stigmatising language (e.g., avoiding terms such as ‘the HD face’), as well as 
the design and implementation of dementia-friendly environments and, 
ultimately, communities (Davis, Byers, Nay, & Koch, 2009; Lin & Lewis, 2015; 
Swaffer, 2014). 
Therefore, due to their focus on specific cognitive, emotional, and social 
components affected by the condition – and in particular their integration into the 
development of potential adaptive circles – the present findings have the 
important clinical implication of carrying a revived incentive towards the 
development of both individual and systemic psychological interventions that may 
help delay or control symptom onset in people affected by Huntington’s disease. 
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Limitations and future directions 
A number of limitations should be acknowledged when considering the 
findings of the present research. First, the initial scoping review of the literature 
(PP1) was limited by the heterogeneity that characterises the terms and 
definitions of communication, and that might have limited the number of retrieved 
citations. Furthermore, despite being functional for the aims and purposes of the 
current thesis, the scoping methodology did not allow for the development of more 
specific research questions. Thus, future literature reviews would benefit from a 
narrower focus on specific elements of communication in HD, and possibly from 
the inclusion of evidence from neuroimaging data.  
The qualitative study on communication perspectives (PP2) was 
characterised by the limit of including only participants from early to moderate 
stage of disease. Moreover, interpretive frameworks other than the SRM may be 
utilised to interpret the results. Future research on perspectives of people with HD 
should aim at involving participants at later stages of disease (possibly adopting 
innovative communication methods such as LiteWriters™), as well as other 
theoretical frameworks. Moreover, further explorations on the concept of 
sheltering are advised, as well as potential implementations of this coping strategy 
into approaches to intervention. 
The online survey with presymptomatic individuals (PP3) carried the 
intrinsic limitation of online studies, namely the lack of direct contact with the 
participants. In addition, the need for brevity led to the adoption of the RME as a 
measure of emotion recognition, which may have not been sensitive enough to 
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detect subtle differences or potential correlations within this specific population. 
Therefore, future research should aim at developing more sensitive measures that 
may be included in online surveys without hampering the brevity required by this 
methodological approach.  
Due to HD’s low prevalence and despite being in line with most 
investigations on the topic, the between-subjects study with symptomatic 
participants (PP4) was characterised by a relatively small sample size. This led to 
limitations in terms of complexity of data analysis and generalizability of the 
findings. Moreover, due to the practical requirements of the data collection 
sessions, no cognitive screening assessment could be performed before 
administering the research materials. The adoption of the BESST with a multiple 
choice forced paradigm also produced generally low emotion recognition rates 
among all the participants. Thus, future investigations on emotion regulation and 
recognition in HD should be included in large multi-centre clinical studies, in order 
to allow for the enrolment of higher numbers of participants, as well as the 
adoption of cognitive screening batteries and more comprehensive measures of 
emotional processing.  
Finally, more research is needed on HD’s impact on sensory and emotional 
processing based on modalities other than the visual one. Indeed, few studies have 
reported impairments in people affected by HD on abilities such as odour 
identification and general olfactory functioning (Bylsma, Moberg, & Doty, 1997; 
Moberg & Doty, 1997; Pirogovsky et al., 2007), as well as emotional processing 
through the auditory (Calder et al., 2010; Hayes, Stevenson, & Coltheart, 2007; 
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Snowden et al., 2008; Sprengelmeyer et al., 1996), olfactory (Sprengelmeyer et al., 
1996; Scahill et al., 2013), and gustatory (Mitchell et al., 2005) modalities. 
Considering the paramount importance of all sensory processes in social and 
communicative contexts (Knapp & Daly, 2011), it is possible to assume that a 
deficit if any of these abilities (e.g., the inability to identify unpleasant smells in the 
surrounding environment) may have significant repercussions on patients’ 
interpersonal relationships. Thus, future studies should investigate the potential 
impact of these impairments on patients’ communicative experiences and daily 
quality of life. 
Statement of contribution 
In the past four years, the opportunity to carry out the investigations at 
the basis of the present thesis has represented to me an outstanding experience of 
personal and professional development as a researcher. In particular, coming from 
a mainly quantitative neuropsychological background developed during my 
foundation degrees, the occasion to adopt a mixed-methods approach has been 
seminal in improving my knowledge of the breadth of methods available to 
psychological research, as well as the importance of subjective experiences in the 
characterisation and understanding of psychological difficulties.  
Moreover, the opportunity to carry out qualitative audio-recorded 
interviews in a language different from my own native has greatly increased my 
understanding of the importance of nonverbal aspects of communication. Indeed, 
by re-listening to my audio recordings in English during the transcription work for 
PP2, I had the chance to realise for the first time how hard it can be to understand 
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verbal messages fully when no nonverbal cues (e.g., facial expressions and body 
language) are provided. This was especially clear to me due to the fact that, as 
evidenced by the recordings, during the interview I did understand the same 
messages without major difficulties.  Needless to say, considering the topic of the 
current thesis, this also helped me from an empirical perspective, allowing me to 
make more informed choices when developing studies focused on nonverbal 
communication.  
The occasion to carry out the data collection at the participants’ home also 
played a pivotal role in teaching me the importance of contextual variables in 
cognitive research. Indeed, since most of my previous clinical experience in 
neuropsychology was based in hospital environments, this kind of activity allowed 
me to observe how deeply cognitive abilities can vary when the participants are in 
a familiar or comfortable place. This was also helpful in the development of the 
concept of sheltering that emerged from the findings of PP2, as well as for the 
observation of the profound beneficial effect that strong familiar or friends’ 
support can have on patients’ mental health and functioning.  
Finally, I probably cannot express how grateful I am for the opportunity I 
have had to work with the HD community. Rarely in any of my previous clinical or 
research experiences have I found such a keen and supportive group of people – 
whether affected individuals, caregivers, or clinicians – who taught me so much 
about the value of generosity, mutual help, dignity, and resilience. If this PhD has 
also contributed to my growth in terms of compassion, I certainly owe it to them.  
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